| Year |
Citation |
Score |
| 2024 |
F De Jesus D, Zhang Z, Brown NK, Li X, Xiao L, Hu J, Gaffrey MJ, Fogarty G, Kahraman S, Wei J, Basile G, Rana TM, Mathews C, Powers AC, Parent AV, Atkinson MA, et al. Redox regulation of mA methyltransferase METTL3 in β-cells controls the innate immune response in type 1 diabetes. Nature Cell Biology. PMID 38409327 DOI: 10.1038/s41556-024-01368-0 |
0.325 |
|
| 2023 |
Foster TP, Jacobsen LM, Bruggeman B, Salmon C, Hosford J, Chen A, Cintron M, Mathews CE, Wasserfall C, Brusko MA, Brusko TM, Atkinson MA, Schatz DA, Haller MJ. Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes. Diabetes Care. PMID 38117469 DOI: 10.2337/dc23-1750 |
0.582 |
|
| 2023 |
Beran D, Koch M, Ajmal S, de Beaufort C, Ramaiya K, Zafra-Tanaka JH, Atkinson M. The Lancet Diabetes & Endocrinology Commission on type 1 diabetes: looking back to move forward. The Lancet. Diabetes & Endocrinology. PMID 37972630 DOI: 10.1016/S2213-8587(23)00323-6 |
0.381 |
|
| 2023 |
Redondo MJ, Harrall KK, Glueck DH, Tosur M, Uysal S, Muir A, Atkinson EG, Shapiro MR, Yu L, Winter WE, Weedon M, Brusko TM, Oram R, Vehik K, Hagopian W, ... Atkinson MA, et al. Diabetes Study of Children of Diverse Ethnicity and Race: Study design. Diabetes/Metabolism Research and Reviews. e3744. PMID 37888801 DOI: 10.1002/dmrr.3744 |
0.63 |
|
| 2023 |
Shapiro MR, Dong X, Perry DJ, McNichols JM, Thirawatananond P, Posgai AL, Peters LD, Motwani K, Musca RS, Muir A, Concannon P, Jacobsen LM, Mathews CE, Wasserfall CH, Haller MJ, ... ... Atkinson MA, et al. Human immune phenotyping reveals accelerated aging in type 1 diabetes. Jci Insight. PMID 37498686 DOI: 10.1172/jci.insight.170767 |
0.587 |
|
| 2023 |
Atkinson MA, Mirmira RG. The pathogenic "symphony" in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas. Cell Metabolism. PMID 37478842 DOI: 10.1016/j.cmet.2023.06.018 |
0.361 |
|
| 2023 |
Matsumoto R, Gray J, Rybkina K, Oppenheimer H, Levy L, Friedman LM, Khamaisi M, Meng W, Rosenfeld AM, Guyer RS, Bradley MC, Chen D, Atkinson MA, Brusko TM, Brusko M, et al. Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunity. Nature Immunology. PMID 37460638 DOI: 10.1038/s41590-023-01557-3 |
0.523 |
|
| 2023 |
Jacobsen LM, Diggins K, Blanchfield L, McNichols JA, Perry DJ, Brant J, Dong X, Bacher R, Gersuk VH, Schatz DA, Atkinson MA, Mathews CE, Haller MJ, Long SA, Linsley PS, et al. Responders to low-dose ATG induce CD4 T cell exhaustion in type 1 diabetes. Jci Insight. PMID 37432736 DOI: 10.1172/jci.insight.161812 |
0.605 |
|
| 2023 |
Connors TJ, Matsumoto R, Verma S, Szabo PA, Guyer R, Gray J, Wang Z, Thapa P, Dogra P, Poon MML, Rybkina K, Bradley MC, Idzikowski E, McNichols J, Kubota M, ... ... Atkinson MA, et al. Site-specific development and progressive maturation of human tissue-resident memory T cells over infancy and childhood. Immunity. PMID 37421943 DOI: 10.1016/j.immuni.2023.06.008 |
0.526 |
|
| 2023 |
Jung S, Nasr MB, Bahmani B, Usuelli V, Zhao J, Sabiu G, Seelam AJ, Naini SM, Balasubramanian HB, Park Y, Li X, Khalefa SA, Kasinath V, Williams MD, Rachid O, ... ... Atkinson MA, et al. Nano-Targeted Delivery of Immune Therapeutics in type 1 Diabetes. Advanced Materials (Deerfield Beach, Fla.). e2300812. PMID 37357903 DOI: 10.1002/adma.202300812 |
0.327 |
|
| 2023 |
Perry DJ, Shapiro MR, Chamberlain SW, Kusmartseva I, Chamala S, Balzano-Nogueira L, Yang M, Brant JO, Brusko M, Williams MD, McGrail KM, McNichols J, Peters LD, Posgai AL, Kaddis JS, ... Atkinson MA, et al. A genomic data archive from the Network for Pancreatic Organ donors with Diabetes. Scientific Data. 10: 323. PMID 37237059 DOI: 10.1038/s41597-023-02244-6 |
0.642 |
|
| 2023 |
Morales JF, Muse R, Podichetty J, Burton J, David S, Lang P, Schmidt S, Romero K, O'Doherty I, Martin F, Campbell-Thompson M, Haller MJ, Atkinson MA, Kim S. Disease Progression Joint Model Predicts Time to Type 1 Diabetes Onset: Optimizing Future Type 1 Diabetes Prevention Studies. Cpt: Pharmacometrics & Systems Pharmacology. PMID 37186151 DOI: 10.1002/psp4.12973 |
0.396 |
|
| 2023 |
De Jesus DF, Zhang Z, Brown NK, Li X, Gaffrey MJ, Kahraman S, Wei J, Hu J, Basile G, Xiao L, Rana TM, Mathews C, Powers AC, Atkinson MA, Eizirik DL, et al. Redox Regulation of m A Methyltransferase METTL3 in Human β-cells Controls the Innate Immune Response in Type 1 Diabetes. Biorxiv : the Preprint Server For Biology. PMID 36824909 DOI: 10.1101/2023.02.16.528701 |
0.312 |
|
| 2023 |
Wilson DM, Pietropaolo SL, Acevedo-Calado M, Huang S, Anyaiwe D, Scheinker D, Steck AK, Vasudevan MM, McKay SV, Sherr JL, Herold KC, Dunne JL, Greenbaum CJ, Lord SM, Haller MJ, ... Atkinson MA, et al. CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study. Diabetes Care. PMID 36730530 DOI: 10.2337/dc22-1297 |
0.342 |
|
| 2022 |
Redondo MJ, Richardson SJ, Perry D, Minard CG, Carr ALJ, Brusko T, Kusmartseva I, Pugliese A, Atkinson MA. Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants. Diabetologia. PMID 36282337 DOI: 10.1007/s00125-022-05818-y |
0.66 |
|
| 2022 |
Kulkarni S, Posgai AL, Kusmartseva I, Wasserfall CH, Atkinson MA, Butler AE. Exocrine and Endocrine Inflammation Increases Cellular Replication in the Pancreatic Duct Compartment in Type 1 Diabetes. Journal of the Endocrine Society. 6: bvac136. PMID 36249412 DOI: 10.1210/jendso/bvac136 |
0.363 |
|
| 2022 |
Shapira SN, Naji A, Atkinson MA, Powers AC, Kaestner KH. Understanding islet dysfunction in type 2 diabetes through multidimensional pancreatic phenotyping: The Human Pancreas Analysis Program. Cell Metabolism. PMID 36206763 DOI: 10.1016/j.cmet.2022.09.013 |
0.348 |
|
| 2022 |
Guo Y, Bian J, Chen A, Wang F, Posgai AL, Schatz DA, Shenkman EA, Atkinson MA. Incidence Trends of New-Onset Diabetes in Children and Adolescents Before and During the COVID-19 Pandemic: Findings from Florida. Diabetes. PMID 36094294 DOI: 10.2337/db22-0549 |
0.331 |
|
| 2022 |
Besançon S, Govender D, Sidibé AT, Noble JA, Togo A, Lane JA, Mack SJ, Atkinson MA, Wasserfall CH, Kakkat F, Martin GGN, Ogle GD. Clinical features, biochemistry, and HLA-DRB1 status in youth-onset type 1 diabetes in Mali. Pediatric Diabetes. PMID 36062396 DOI: 10.1111/pedi.13411 |
0.327 |
|
| 2022 |
Ismail HM, Cuthbertson D, Gitelman SE, Skyler JS, Steck AK, Rodriguez H, Atkinson M, Nathan BM, Redondo MJ, Herold KC, Evans-Molina C, DiMeglio LA, Sosenko J. The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk. Diabetes Care. PMID 35998266 DOI: 10.2337/dc22-0167 |
0.312 |
|
| 2022 |
Girdhar K, Huang Q, Chow IT, Vatanen T, Brady C, Raisingani A, Autissier P, Atkinson MA, Kwok WW, Kahn CR, Altindis E. A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes. Proceedings of the National Academy of Sciences of the United States of America. 119: e2120028119. PMID 35878027 DOI: 10.1073/pnas.2120028119 |
0.324 |
|
| 2022 |
Dunne JL, Maizel JL, Posgai AL, Atkinson MA, DiMeglio LA. The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes. 70: 1623-1633. PMID 35381061 DOI: 10.2337/db21-0052 |
0.32 |
|
| 2022 |
O'Kell AL, Shome M, Qiu J, Williams S, Chung Y, LaBaer J, Atkinson MA, Wasserfall C. Exploration of autoantibody responses in canine diabetes using protein arrays. Scientific Reports. 12: 2490. PMID 35169238 DOI: 10.1038/s41598-022-06599-5 |
0.371 |
|
| 2022 |
Kaddis JS, Perry DJ, Vu AN, Rich SS, Atkinson MA, Schatz DA, Roep BO, Brusko TM. Improving the Prediction of Type 1 Diabetes Across Ancestries. Diabetes Care. PMID 35043156 DOI: 10.2337/dc21-1254 |
0.625 |
|
| 2021 |
Michels AW, Redondo MJ, Atkinson MA. The pathogenesis, natural history, and treatment of type 1 diabetes: time (thankfully) does not stand still. The Lancet. Diabetes & Endocrinology. PMID 34951951 DOI: 10.1016/S2213-8587(21)00344-2 |
0.345 |
|
| 2021 |
Bruggeman BS, Campbell-Thompson M, Filipp SL, Gurka MJ, Atkinson MA, Schatz DA, Jacobsen LM. Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies. Frontiers in Endocrinology. 12: 778912. PMID 34912300 DOI: 10.3389/fendo.2021.778912 |
0.351 |
|
| 2021 |
Missarova A, Jain J, Butler A, Ghazanfar S, Stuart T, Brusko M, Wasserfall C, Nick H, Brusko T, Atkinson M, Satija R, Marioni JC. geneBasis: an iterative approach for unsupervised selection of targeted gene panels from scRNA-seq. Genome Biology. 22: 333. PMID 34872616 DOI: 10.1186/s13059-021-02548-z |
0.505 |
|
| 2021 |
O'Kell AL, Wasserfall C, Guingab-Cagmat J, Webb-Roberston BM, Atkinson MA, Garrett TJ. Targeted metabolomic analysis identifies increased serum levels of GABA and branched chain amino acids in canine diabetes. Metabolomics : Official Journal of the Metabolomic Society. 17: 100. PMID 34775536 DOI: 10.1007/s11306-021-01850-y |
0.363 |
|
| 2021 |
Wu M, Lee MYY, Bahl V, Traum D, Schug J, Kusmartseva I, Atkinson MA, Fan G, Kaestner KH. Single-cell analysis of the human pancreas in type 2 diabetes using multi-spectral imaging mass cytometry. Cell Reports. 37: 109919. PMID 34731614 DOI: 10.1016/j.celrep.2021.109919 |
0.414 |
|
| 2021 |
Anderson AM, Landry LG, Alkanani AA, Pyle L, Powers AC, Atkinson MA, Mathews CE, Roep BO, Michels AW, Nakayama M. Human islet T cells are highly reactive to preproinsulin in type 1 diabetes. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34611019 DOI: 10.1073/pnas.2107208118 |
0.358 |
|
| 2021 |
Voss MG, Cuthbertson DD, Cleves MM, Xu P, Evans-Molina C, Palmer JP, Redondo MJ, Steck AK, Lundgren M, Larsson H, Moore WV, Atkinson MA, Sosenko JM, Ismail HM. Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts. Diabetes Care. PMID 34362815 DOI: 10.2337/dc21-0226 |
0.348 |
|
| 2021 |
Roep BO, Montero E, van Tienhoven R, Atkinson MA, Schatz DA, Mathieu C. Defining a cure for type 1 diabetes: a call to action. The Lancet. Diabetes & Endocrinology. PMID 34339632 DOI: 10.1016/S2213-8587(21)00181-9 |
0.376 |
|
| 2021 |
Perry DJ, Peters LD, Lakshmi PS, Zhang L, Han Z, Wasserfall CH, Mathews CE, Atkinson MA, Brusko TM. Overexpression of the Autoimmune Risk Variant LYP-620W Fails to Restrain Human CD4 T Cell Activation. Journal of Immunology (Baltimore, Md. : 1950). PMID 34301848 DOI: 10.4049/jimmunol.2000708 |
0.602 |
|
| 2021 |
Hiller H, Beachy DE, Lebowitz JJ, Engler S, Mason JR, Miller DR, Kusmarteva I, Jacobsen LM, Posgai AL, Khoshbouei H, Oram RA, Schatz DA, Hattersley AT, Bodenmiller B, Atkinson MA, et al. Monogenic Diabetes and Integrated Stress Response Genes Display Altered Gene Expression in Type 1 Diabetes. Diabetes. PMID 34035041 DOI: 10.2337/db21-0070 |
0.368 |
|
| 2021 |
Beam CA, Beli E, Wasserfall CH, Woerner SE, Legge MT, Evans-Molina C, McGrail KM, Silk R, Grant MB, Atkinson MA, DiMeglio LA. Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes. Diabetologia. PMID 34003304 DOI: 10.1007/s00125-021-05468-6 |
0.359 |
|
| 2021 |
Rodriguez-Calvo T, Chen YC, Verchere CB, Haataja L, Arvan P, Leete P, Richardson SJ, Morgan NG, Qian WJ, Pugliese A, Atkinson M, Evans-Molina C, Sims EK. Altered β-Cell Prohormone Processing and Secretion in Type 1 Diabetes. Diabetes. PMID 33947721 DOI: 10.2337/dbi20-0034 |
0.376 |
|
| 2021 |
Landry LG, Anderson AM, Russ HA, Yu L, Kent SC, Atkinson MA, Mathews CE, Michels AW, Nakayama M. Proinsulin-Reactive CD4 T Cells in the Islets of Type 1 Diabetes Organ Donors. Frontiers in Endocrinology. 12: 622647. PMID 33841327 DOI: 10.3389/fendo.2021.622647 |
0.303 |
|
| 2021 |
Atkinson MA, Powers AC. Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes? The Lancet. Diabetes & Endocrinology. PMID 33838106 DOI: 10.1016/S2213-8587(21)00087-5 |
0.351 |
|
| 2021 |
Campbell-Thompson M, Butterworth EA, Boatwright JL, Nair MA, Nasif LH, Nasif K, Revell AY, Riva A, Mathews CE, Gerling IC, Schatz DA, Atkinson MA. Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes. Scientific Reports. 11: 6562. PMID 33753784 DOI: 10.1038/s41598-021-85659-8 |
0.318 |
|
| 2021 |
Nandedkar-Kulkarni N, Esakov E, Gregg B, Atkinson MA, Rogers DG, Horner JD, Singer K, Lundy SK, Felton JL, Al-Huniti T, Kalinoski AN, Morran MP, Gupta NK, Bretz JD, Balaji S, et al. Insulin Receptor-Expressing T Cells Appear in Individuals at Risk for Type 1 Diabetes and Can Move into the Pancreas in C57BL/6 Transgenic Mice. Journal of Immunology (Baltimore, Md. : 1950). PMID 33658296 DOI: 10.4049/jimmunol.1900357 |
0.341 |
|
| 2021 |
Lin A, Mack JA, Bruggeman B, Jacobsen LM, Posgai AL, Wasserfall CH, Brusko TM, Atkinson MA, Gitelman SE, Gottlieb PA, Gurka MJ, Mathews CE, Schatz DA, Haller MJ. Low-dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report. Diabetes. PMID 33632742 DOI: 10.2337/db20-1103 |
0.614 |
|
| 2021 |
Japp AS, Meng W, Rosenfeld AM, Perry DJ, Thirawatananond P, Bacher RL, Liu C, Gardner JS, Atkinson MA, Kaestner KH, Brusko TM, Naji A, Luning Prak ET, Betts MR. TCR/BCR dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes. Cell. 184: 827-839.e14. PMID 33545036 DOI: 10.1016/j.cell.2020.11.035 |
0.59 |
|
| 2021 |
Ciecko AE, Foda B, Barr JY, Ramanathan S, Atkinson MA, Serreze DV, Geurts AM, Lieberman SM, Chen YG. Interleukin-27 is essential for type 1 diabetes development and Sjögren syndrome-like inflammation. Cell Reports. 34: 108725. PMID 33535031 DOI: 10.1016/j.celrep.2021.108725 |
0.341 |
|
| 2021 |
Balzano-Nogueira L, Ramirez R, Zamkovaya T, Dailey J, Ardissone AN, Chamala S, Serrano-Quílez J, Rubio T, Haller MJ, Concannon P, Atkinson MA, Schatz DA, Triplett EW, Conesa A. Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes. Genome Biology. 22: 39. PMID 33478573 DOI: 10.1186/s13059-021-02262-w |
0.373 |
|
| 2021 |
Petrelli A, Atkinson MA, Pietropaolo M, Giannoukakis N. Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes. Diabetes. 70: 313-322. PMID 33472941 DOI: 10.2337/dbi20-0026 |
0.37 |
|
| 2021 |
Ross JJ, Wasserfall CH, Bacher R, Perry DJ, McGrail K, Posgai AL, Dong X, Muir A, Li X, Campbell-Thompson M, Brusko TM, Schatz DA, Haller MJ, Atkinson MA. Exocrine Pancreatic Enzymes Are a Serological Biomarker for Type 1 Diabetes Staging and Pancreas Size. Diabetes. PMID 33441381 DOI: 10.2337/db20-0995 |
0.646 |
|
| 2021 |
Williams MD, Bacher R, Perry DJ, Grace CR, McGrail KM, Posgai AL, Muir A, Chamala S, Haller MJ, Schatz DA, Brusko TM, Atkinson MA, Wasserfall CH. Genetic Composition and Autoantibody Titers Model the Probability of Detecting C-Peptide Following Type 1 Diabetes Diagnosis. Diabetes. PMID 33419759 DOI: 10.2337/db20-0937 |
0.626 |
|
| 2020 |
Walker AF, Atkinson MA, Lee AM, Aulisio G, Brusko TM, Haller MJ, Schatz DA. Teaching Type 1 Diabetes: Creating Stakeholder Engagement in Biomedical Careers Through Undergraduate Research Curriculum. Medical Science Educator. 30: 69-73. PMID 34457640 DOI: 10.1007/s40670-019-00877-0 |
0.542 |
|
| 2020 |
Foster TP, Bruggeman B, Campbell-Thompson M, Atkinson MA, Haller MJ, Schatz DA. Exocrine Pancreas Dysfunction in Type 1 Diabetes. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 26: 1505-1513. PMID 33471743 DOI: 10.4158/Ep-2020-0295 |
0.483 |
|
| 2020 |
O'Kell AL, Wasserfall CH, Henthorn PS, Atkinson MA, Hess RS. Evaluation for type 1 diabetes associated autoantibodies in diabetic and non-diabetic Australian terriers and Samoyeds. Canine Medicine and Genetics. 7: 10. PMID 33323126 DOI: 10.1186/s40575-020-00089-5 |
0.386 |
|
| 2020 |
Tang X, Kusmartseva I, Kulkarni S, Posgai A, Speier S, Schatz DA, Haller MJ, Campbell-Thompson M, Wasserfall CH, Roep BO, Kaddis JS, Atkinson MA. Image-based machine learning algorithms for disease characterization in the human type 1 diabetes pancreas. The American Journal of Pathology. PMID 33307036 DOI: 10.1016/j.ajpath.2020.11.010 |
0.396 |
|
| 2020 |
Brusko MA, Stewart JM, Posgai AL, Wasserfall CH, Atkinson MA, Brusko TM, Keselowsky BG. Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell Responses. Frontiers in Immunology. 11: 574447. PMID 33193362 DOI: 10.3389/fimmu.2020.574447 |
0.606 |
|
| 2020 |
Shapiro MR, Yeh WI, Longfield JR, Gallagher J, Infante CM, Wellford S, Posgai AL, Atkinson MA, Campbell-Thompson M, Lieberman SM, Serreze DV, Geurts AM, Chen YG, Brusko TM. CD226 Deletion Reduces Type 1 Diabetes in the NOD Mouse by Impairing Thymocyte Development and Peripheral T Cell Activation. Frontiers in Immunology. 11: 2180. PMID 33013915 DOI: 10.3389/Fimmu.2020.02180 |
0.658 |
|
| 2020 |
Atkinson MA, Campbell-Thompson M, Kusmartseva I, Kaestner KH. Organisation of the human pancreas in health and in diabetes. Diabetologia. 63: 1966-1973. PMID 32894306 DOI: 10.1007/S00125-020-05203-7 |
0.46 |
|
| 2020 |
Walejko JM, Chelliah A, Keller-Wood M, Wasserfall C, Atkinson M, Gregg A, Edison AS. Diabetes Leads to Alterations in Normal Metabolic Transitions of Pregnancy as Revealed by Time-Course Metabolomics. Metabolites. 10. PMID 32867274 DOI: 10.3390/Metabo10090350 |
0.33 |
|
| 2020 |
Jacobsen L, Bundy B, Greco M, Schatz D, Atkinson M, Brusko T, Mathews C, Herold KC, Gitelman S, Krischer J, Haller M. Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 Diabetes. Diabetes Technology & Therapeutics. PMID 32833543 DOI: 10.1089/Dia.2020.0305 |
0.606 |
|
| 2020 |
Carr ALJ, Perry DJ, Lynam AL, Chamala S, Flaxman CS, Sharp SA, Ferrat LA, Jones AG, Beery ML, Jacobsen LM, Wasserfall CH, Campbell-Thompson ML, Kusmartseva I, Posgai A, Schatz DA, Atkinson MA, et al. Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes. Diabetic Medicine : a Journal of the British Diabetic Association. PMID 32634859 DOI: 10.1111/Dme.14361 |
0.667 |
|
| 2020 |
Qadir MMF, Álvarez-Cubela S, Weitz J, Panzer JK, Klein D, Moreno-Hernández Y, Cechin S, Tamayo A, Almaça J, Hiller H, Beery M, Kusmartseva I, Atkinson M, Speier S, Ricordi C, et al. Long-term culture of human pancreatic slices as a model to study real-time islet regeneration. Nature Communications. 11: 3265. PMID 32601271 DOI: 10.1038/S41467-020-17040-8 |
0.363 |
|
| 2020 |
Cook DP, Cunha JPMCM, Martens PJ, Sassi G, Mancarella F, Ventriglia G, Sebastiani G, Vanherwegen AS, Atkinson MA, Van Huynegem K, Steidler L, Caluwaerts S, Rottiers P, Teyton L, Dotta F, et al. Intestinal Delivery of Proinsulin and IL-10 via Combined With Low-Dose Anti-CD3 Restores Tolerance Outside the Window of Acute Type 1 Diabetes Diagnosis. Frontiers in Immunology. 11: 1103. PMID 32582188 DOI: 10.3389/Fimmu.2020.01103 |
0.488 |
|
| 2020 |
Neiman D, Gillis D, Piyanzin S, Cohen D, Fridlich O, Moss J, Zick A, Oron T, Sundberg F, Forsander G, Skog O, Korsgren O, Levy-Khademi F, Arbell D, Hashavya S, ... ... Atkinson MA, et al. Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic beta-cells. Jci Insight. PMID 32573495 DOI: 10.1172/Jci.Insight.136579 |
0.376 |
|
| 2020 |
de Boer P, Pirozzi NM, Wolters AHG, Kuipers J, Kusmartseva I, Atkinson MA, Campbell-Thompson M, Giepmans BNG. Large-scale electron microscopy database for human type 1 diabetes. Nature Communications. 11: 2475. PMID 32424134 DOI: 10.1038/S41467-020-16287-5 |
0.501 |
|
| 2020 |
Panzer JK, Hiller H, Cohrs CM, Almaça J, Enos SJ, Beery M, Cechin S, Drotar DM, Weitz JR, Santini J, Huber MK, Muhammad Fahd Qadir M, Pastori RL, Domínguez-Bendala J, Phelps EA, ... Atkinson MA, et al. Pancreas tissue slices from organ donors enable in situ analysis of type 1 diabetes pathogenesis. Jci Insight. 5. PMID 32324170 DOI: 10.1172/Jci.Insight.134525 |
0.439 |
|
| 2020 |
Sims EK, Geyer S, Johnson SB, Libman I, Jacobsen LM, Boulware D, Rafkin LE, Matheson D, Atkinson MA, Rodriguez H, Spall M, Larsson HE, Wherrett DK, Greenbaum CJ, Krischer J, et al. Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care 2019;42:2228-2236. Diabetes Care. PMID 32132004 DOI: 10.2337/Dc20-Er04 |
0.474 |
|
| 2020 |
Dean JW, Peters LD, Fuhrman CA, Seay HR, Posgai AL, Stimpson SE, Brusko MA, Perry DJ, Yeh WI, Newby BN, Haller MJ, Muir AB, Atkinson MA, Mathews CE, Brusko TM. Innate inflammation drives NK cell activation to impair Treg activity. Journal of Autoimmunity. 102417. PMID 32035746 DOI: 10.1016/J.Jaut.2020.102417 |
0.58 |
|
| 2020 |
Ismail HM, Becker DJ, Libman I, Herold KC, Redondo MJ, Atkinson MA, Cleves MA, Palmer J, Sosenko J. Early and Late C-peptide Responses during Oral Glucose Tolerance Testing are Oppositely Predictive of Type 1 Diabetes in Autoantibody Positive Individuals. Diabetes, Obesity & Metabolism. PMID 32003110 DOI: 10.1111/Dom.13982 |
0.409 |
|
| 2020 |
Beam CA, Wasserfall C, Woodwyk A, Akers M, Rauch H, Blok T, Mason P, Vos D, Perry D, Brusko T, Peakman M, Atkinson M. Synchronization of the Normal Human Peripheral Immune System: A Comprehensive Circadian Systems Immunology Analysis. Scientific Reports. 10: 672. PMID 31959869 DOI: 10.1038/S41598-019-56951-5 |
0.582 |
|
| 2020 |
Sims EK, Geyer S, Johnson SB, Libman I, Jacobsen LM, Boulware D, Rafkin LE, Matheson D, Atkinson MA, Rodriguez H, Spall M, Larsson HE, Wherrett DK, Greenbaum CJ, Krischer J, et al. Erratum: Who is enrolling? The path to monitoring in type 1 diabetes trialnet’s pathway to prevention (Diabetes care (2019) 42 (2228–2236) DOI: 10.2337/dc19-0593) Diabetes Care. 43. DOI: 10.2337/Dc20Er04 |
0.458 |
|
| 2020 |
Evans-Molina C, Saeed ZI, Sosenko J, Atkinson MA, Herold KC, Ismail HM, Larsson HE, Lundgren M, Moran A, Moore DJ, Nathan BM, Palmer JP, Sims EK, Steck A, Wherrett DK, et al. 348-OR: Metabolic Phenotype of Autoantibody Positive (AbPos) Long-Term Nonprogressors (LTNPs) to Type 1 Diabetes (T1D) Diabetes. 69. DOI: 10.2337/Db20-348-Or |
0.333 |
|
| 2020 |
LIN A, PERRY DJ, SCHATZ D, BRUSKO TM, ATKINSON MA, HALLER MJ, MATHEWS CE. 253-OR: Circulating Neutrophil Numbers Increase with Age, but Are Not a Biomarker of T1D Risk Diabetes. 69: 253-OR. DOI: 10.2337/Db20-253-Or |
0.538 |
|
| 2020 |
Rubio V, Chamberlain CA, Wasserfall C, Guevara-Aguirre J, Guevara A, Rosenbloom AL, Atkinson MA, Yost RA, Garrett TJ. 195-LB: Metabolomic Characterization of Laron and Guevara-Rosenbloom Syndromes Using UHPLC-HRMS Diabetes. 69. DOI: 10.2337/Db20-195-Lb |
0.361 |
|
| 2019 |
Redondo MJ, Sosenko J, Libman I, McVean JJF, Tosur M, Atkinson MA, Becker D, Geyer S. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated with Older Age and Insulin Resistance. The Journal of Clinical Endocrinology and Metabolism. PMID 31867614 DOI: 10.1210/Clinem/Dgz296 |
0.459 |
|
| 2019 |
Shapiro MR, Wasserfall CH, McGrail SM, Posgai AL, Bacher R, Muir A, Haller MJ, Schatz DA, Wesley JD, von Herrath M, Hagopian WA, Speake C, Atkinson MA, Brusko TM. Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes Diagnosis. Diabetes. PMID 31826866 DOI: 10.2337/Db19-0942 |
0.652 |
|
| 2019 |
Ciecko AE, Foda B, Barr JY, Ramanathan S, Atkinson MA, Serreze DV, Geurts AM, Lieberman SM, Chen YG. Interleukin-27 Is Essential for Type 1 Diabetes Development and Sjögren Syndrome-like Inflammation. Cell Reports. 29: 3073-3086.e5. PMID 31801074 DOI: 10.1016/J.Celrep.2019.11.010 |
0.405 |
|
| 2019 |
Jacobsen LM, Bocchino L, Evans-Molina C, DiMeglio L, Goland R, Wilson DM, Atkinson MA, Aye T, Russell WE, Wentworth JM, Boulware D, Geyer S, Sosenko JM. The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening. Diabetologia. PMID 31768570 DOI: 10.1007/S00125-019-05047-W |
0.385 |
|
| 2019 |
Battaglia M, Ahmed S, Anderson MS, Atkinson MA, Becker D, Bingley PJ, Bosi E, Brusko TM, DiMeglio LA, Evans-Molina C, Gitelman SE, Greenbaum CJ, Gottlieb PA, Herold KC, Hessner MJ, et al. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes. Diabetes Care. PMID 31753960 DOI: 10.2337/Dc19-0880 |
0.669 |
|
| 2019 |
Kusmartseva I, Beery M, Hiller H, Padilla M, Selman S, Posgai A, Nick HS, Campbell-Thompson M, Schatz DA, Haller MJ, Wasserfall CH, Atkinson MA. Temporal Analysis of Amylase Expression in Control, Autoantibody Positive, and Type 1 Diabetes Pancreatic Tissues. Diabetes. PMID 31597639 DOI: 10.2337/Db19-0554 |
0.474 |
|
| 2019 |
Sims EK, Geyer S, Johnson SB, Libman I, Jacobsen LM, Boulware D, Rafkin LE, Matheson D, Atkinson MA, Rodriguez H, Spall M, Larsson HE, Wherrett DK, Greenbaum CJ, Krischer J, et al. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care. PMID 31558546 DOI: 10.2337/Dc19-0593 |
0.464 |
|
| 2019 |
Ma H, Lu Y, Lowe K, van der Meijden-Erkelens L, Wasserfall C, Atkinson MA, Song S. Regulated hAAT Expression from a Novel rAAV Vector and Its Application in the Prevention of Type 1 Diabetes. Journal of Clinical Medicine. 8. PMID 31466263 DOI: 10.3390/Jcm8091321 |
0.403 |
|
| 2019 |
Russell JT, Roesch LFW, Ördberg M, Ilonen J, Atkinson MA, Schatz DA, Triplett EW, Ludvigsson J. Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome. Nature Communications. 10: 3621. PMID 31399563 DOI: 10.1038/S41467-019-11460-X |
0.374 |
|
| 2019 |
Kehlenbrink S, Jaacks LM, Perone SA, Ansbro É, Ashbourne E, Atkinson C, Atkinson M, Atun R, Besançon S, Boulle P, Bygrave H, Caballero E, Cooper K, Cristello A, Digovich K, et al. Diabetes in humanitarian crises: the Boston Declaration. The Lancet Diabetes & Endocrinology. 7: 590-592. PMID 31178312 DOI: 10.1016/S2213-8587(19)30197-4 |
0.47 |
|
| 2019 |
Redondo MJ, Evans-Molina C, Steck AK, Atkinson MA, Sosenko J. The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes. Diabetes Care. PMID 31167894 DOI: 10.2337/Dc19-0102 |
0.512 |
|
| 2019 |
Shapiro MR, Atkinson MA, Brusko TM. Pleiotropic roles of the insulin-like growth factor axis in type 1 diabetes. Current Opinion in Endocrinology, Diabetes, and Obesity. PMID 31145130 DOI: 10.1097/Med.0000000000000484 |
0.647 |
|
| 2019 |
Kaestner KH, Powers AC, Naji A, Atkinson MA. NIH Initiative to Improve Understanding of the Pancreas, Islet, and Autoimmunity in Type 1 Diabetes: The Human Pancreas Analysis Program (HPAP). Diabetes. PMID 31127054 DOI: 10.2337/Db19-0058 |
0.506 |
|
| 2019 |
Lewis JS, Stewart JM, Marshall GP, Carstens MR, Zhang Y, Dolgova NV, Xia C, Brusko TM, Wasserfall CH, Clare-Salzler MJ, Atkinson MA, Keselowsky BG. Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model. Acs Biomaterials Science & Engineering. 5: 2631-2646. PMID 31119191 DOI: 10.1021/Acsbiomaterials.9B00332 |
0.702 |
|
| 2019 |
Beery ML, Jacobsen LM, Atkinson MA, Butler AE, Campbell-Thompson M. Islet amyloidosis in a child with type 1 diabetes. Islets. 1-6. PMID 31084520 DOI: 10.1080/19382014.2019.1599707 |
0.502 |
|
| 2019 |
Dunne JL, Richardson SJ, Atkinson MA, Craig ME, Dahl-Jørgensen K, Flodström-Tullberg M, Hyöty H, Lloyd RE, Morgan NG, Pugliese A. Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter]. Diabetologia. PMID 31016358 DOI: 10.1007/S00125-019-4873-6 |
0.328 |
|
| 2019 |
Haller MJ, Long SA, Blanchfield JL, Schatz DA, Skyler JS, Krischer JP, Bundy BN, Geyer SM, Warnock MV, Miller JL, Atkinson MA, Becker DJ, Baidal DA, DiMeglio LA, Gitelman SE, et al. Low-dose Anti-Thymocyte Globulin Preserves C-Peptide and Reduces A1c in New Onset Type 1 Diabetes: Two Year Clinical Trial Data. Diabetes. PMID 30967424 DOI: 10.2337/Db19-0057 |
0.463 |
|
| 2019 |
Yong J, Tian J, Dang H, Wu TT, Atkinson MA, Sun R, Kaufman DL. Increased risk for T cell autoreactivity to ß-cell antigens in the mice expressing the A obesity-associated gene. Scientific Reports. 9: 4269. PMID 30862859 DOI: 10.1038/S41598-019-38905-Z |
0.338 |
|
| 2019 |
O'Kell AL, Garrett TJ, Wasserfall C, Atkinson MA. Untargeted metabolomic analysis in non-fasted diabetic dogs by UHPLC-HRMS. Metabolomics : Official Journal of the Metabolomic Society. 15: 15. PMID 30830416 DOI: 10.1007/S11306-019-1477-6 |
0.476 |
|
| 2019 |
Thompson PJ, Shah A, Ntranos V, Van Gool F, Atkinson M, Bhushan A. Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes. Cell Metabolism. PMID 30799288 DOI: 10.1016/J.Cmet.2019.01.021 |
0.411 |
|
| 2019 |
Wang YJ, Traum D, Schug J, Gao L, Liu C, Atkinson MA, Powers AC, Feldman MD, Naji A, Chang KM, Kaestner KH. Multiplexed In Situ Imaging Mass Cytometry Analysis of the Human Endocrine Pancreas and Immune System in Type 1 Diabetes. Cell Metabolism. PMID 30713110 DOI: 10.1016/J.Cmet.2019.01.003 |
0.48 |
|
| 2019 |
Damond N, Engler S, Zanotelli VRT, Schapiro D, Wasserfall CH, Kusmartseva I, Nick HS, Thorel F, Herrera PL, Atkinson MA, Bodenmiller B. A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry. Cell Metabolism. PMID 30713109 DOI: 10.1016/J.Cmet.2018.11.014 |
0.438 |
|
| 2019 |
Dunne JL, Richardson SJ, Atkinson MA, Craig ME, Dahl-Jørgensen K, Flodström-Tullberg M, Hyöty H, Insel RA, Lernmark Å, Lloyd RE, Morgan NG, Pugliese A. Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes. Diabetologia. PMID 30675626 DOI: 10.1007/S00125-019-4811-7 |
0.477 |
|
| 2019 |
Onengut-Gumuscu S, Chen WM, Robertson CC, Bonnie JK, Farber E, Zhu Z, Oksenberg JR, Brant SR, Bridges SL, Edberg JC, Kimberly RP, Gregersen PK, Rewers MJ, Steck AK, Black MH, ... Atkinson MA, et al. Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score. Diabetes Care. PMID 30659077 DOI: 10.2337/Dc18-1727 |
0.429 |
|
| 2019 |
Campbell-Thompson ML, Filipp SL, Grajo JR, Nambam B, Beegle R, Middlebrooks EH, Gurka MJ, Atkinson MA, Schatz DA, Haller MJ. Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes. Diabetes Care. 42: 281-287. PMID 30552130 DOI: 10.2337/Dc18-1512 |
0.471 |
|
| 2019 |
Atkinson MA, Roep BO, Posgai A, Wheeler DCS, Peakman M. The challenge of modulating β-cell autoimmunity in type 1 diabetes. The Lancet. Diabetes & Endocrinology. 7: 52-64. PMID 30528099 DOI: 10.1016/S2213-8587(18)30112-8 |
0.468 |
|
| 2019 |
Nelson G, Lenchik NI, Campbell-Thompson M, Mathews CE, Atkinson MA, Gerling IC. 93-OR: Expression of Genes Associated with Host Viral Responses in Insulitic Islets Diabetes. 68. DOI: 10.2337/Db19-93-Or |
0.375 |
|
| 2019 |
Beli E, Dimeglio L, Woerner S, Evans-Molina C, Mcgrail KM, Wasserfall C, Atkinson MA, Beam C. 1729-P: Circadian Patterns of Autoimmune Components in the Blood of Persons with Type 1 Diabetes: Implications for the Timing of Blood Sampling Diabetes. 68. DOI: 10.2337/Db19-1729-P |
0.417 |
|
| 2019 |
ISMAIL HM, BUNDY BN, ATKINSON MA, MOORE WV, HALLER MJ, RUSSELL WE, GITELMAN SE, HEROLD KC, REDONDO MJ, SOSENKO JM. 1689-P: Assessments of Alternative C-Peptide (C-P) Endpoints for New-Onset Type 1 Diabetes (T1D) Clinical Trials Diabetes. 68: 1689-P. DOI: 10.2337/Db19-1689-P |
0.368 |
|
| 2019 |
HALLER MJ, GRECO MN, SCHATZ D, ATKINSON MA, BRUSKO TM, MATHEWS CE, JACOBSEN LM, HEROLD KC, GITELMAN SE, KRISCHER J, BUNDY BN. 164-OR: Efficacy of New-Onset Type 1 Diabetes (T1D) Intervention Trials: Variation in 1-Year Outcomes Diabetes. 68: 164-OR. DOI: 10.2337/Db19-164-Or |
0.575 |
|
| 2019 |
Bruggeman BS, Campbell-Thompson M, Posgai AL, Atkinson MA, Schatz D, Jacobsen LM. 1366-P: Effect of Substance Use on Type 1 Diabetes (T1D) Pancreas Histopathology Diabetes. 68. DOI: 10.2337/Db19-1366-P |
0.344 |
|
| 2019 |
Ismail HM, Becker DJ, Libman I, Herold KC, Redondo MJ, Atkinson MA, Cleves MA, Palmer J, Sosenko J. Author response for "Early and Late C‐peptide Responses during Oral Glucose Tolerance Testing are Oppositely Predictive of Type 1 Diabetes in Autoantibody Positive Individuals" Diabetes, Obesity and Metabolism. DOI: 10.1111/Dom.13982/V2/Response1 |
0.397 |
|
| 2019 |
Walker AF, Atkinson MA, Lee AM, Aulisio G, Brusko TM, Haller MJ, Schatz DA. Teaching Type 1 Diabetes: Creating Stakeholder Engagement in Biomedical Careers Through Undergraduate Research Curriculum Medical Science Educator. 30: 69-73. DOI: 10.1007/S40670-019-00877-0 |
0.586 |
|
| 2018 |
Redondo MJ, Steck AK, Sosenko J, Anderson M, Antinozzi P, Michels A, Wentworth JM, Atkinson MA, Pugliese A, Geyer S. Transcription Factor 7-Like 2 () Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes. Diabetes Care. PMID 30275285 DOI: 10.2337/Dc18-0861 |
0.488 |
|
| 2018 |
Dou M, Zhu Y, Liyu A, Liang Y, Chen J, Piehowski PD, Xu K, Zhao R, Moore RJ, Atkinson MA, Mathews CE, Qian WJ, Kelly RT. Nanowell-mediated two-dimensional liquid chromatography enables deep proteome profiling of <1000 mammalian cells. Chemical Science. 9: 6944-6951. PMID 30210768 DOI: 10.1039/C8Sc02680G |
0.4 |
|
| 2018 |
Tezza S, Ben Nasr M, D'Addio F, Vergani A, Usuelli V, Falzoni S, Bassi R, Dellepiane S, Fotino C, Rossi C, Maestroni A, Solini A, Corradi D, Giani E, Mameli C, ... ... Atkinson MA, et al. Islet-Derived eATP Fuels Autoreactive CD8 Cells and Facilitates the Onset of Type 1 Diabetes. Diabetes. PMID 30065030 DOI: 10.2337/Db17-1227 |
0.464 |
|
| 2018 |
Haller MJ, Schatz DA, Skyler JS, Krischer JP, Bundy BN, Miller JL, Atkinson MA, Becker DJ, Baidal D, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Herold KC, Marks JB, et al. Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA in New-Onset Type 1 Diabetes. Diabetes Care. PMID 30012675 DOI: 10.2337/Dc18-0494 |
0.413 |
|
| 2018 |
Redondo MJ, Geyer S, Steck AK, Sharp S, Wentworth JM, Weedon MN, Antinozzi P, Sosenko J, Atkinson M, Pugliese A, Oram RA. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. Diabetes Care. PMID 30002199 DOI: 10.2337/Dc18-0087 |
0.436 |
|
| 2018 |
Canzano JS, Nasif LH, Butterworth EA, Fu DA, Atkinson MA, Campbell-Thompson M. Islet Microvasculature Alterations With Loss of Beta-cells in Patients With Type 1 Diabetes. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 22155418778546. PMID 29771178 DOI: 10.1369/0022155418778546 |
0.476 |
|
| 2018 |
Greenbaum CJ, Speake C, Krischer J, Buckner J, Gottlieb PA, Schatz DA, Herold KC, Atkinson MA. Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes-The TrialNet Experience. Diabetes. PMID 29769238 DOI: 10.2337/Db18-0065 |
0.473 |
|
| 2018 |
Bingley PJ, Wherrett DK, Shultz A, Rafkin LE, Atkinson MA, Greenbaum CJ. Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes. Diabetes Care. 41: 653-661. PMID 29559451 DOI: 10.2337/dc17-0806 |
0.328 |
|
| 2018 |
Perry DJ, Wasserfall CH, Oram RA, Williams MD, Posgai A, Muir AB, Haller MJ, Schatz DA, Wallet MA, Mathews CE, Atkinson MA, Brusko TM. Application of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling. Scientific Reports. 8: 4529. PMID 29540798 DOI: 10.1038/S41598-018-22574-5 |
0.601 |
|
| 2018 |
Brissova M, Haliyur R, Saunders D, Shrestha S, Dai C, Blodgett DM, Bottino R, Campbell-Thompson M, Aramandla R, Poffenberger G, Lindner J, Pan FC, von Herrath MG, Greiner DL, Shultz LD, ... Atkinson M, et al. α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes. Cell Reports. 22: 2667-2676. PMID 29514095 DOI: 10.1016/J.Celrep.2018.02.032 |
0.404 |
|
| 2018 |
Ostrov DA, Alkanani A, McDaniel KA, Case S, Baschal EE, Pyle L, Ellis S, Pöllinger B, Seidl KJ, Shah VN, Garg SK, Atkinson MA, Gottlieb PA, Michels AW. Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes. The Journal of Clinical Investigation. PMID 29438107 DOI: 10.1172/Jci97739 |
0.459 |
|
| 2018 |
Smith MJ, Rihanek M, Wasserfall C, Mathews CE, Atkinson MA, Gottlieb PA, Cambier JC. Loss of B Cell Anergy in Type 1 Diabetes is Associated with High Risk HLA and non-HLA Disease Susceptibility Alleles. Diabetes. PMID 29343548 DOI: 10.2337/Db17-0937 |
0.455 |
|
| 2018 |
Bosi E, Geyer S, Sosenko J, Becker DJ, Battaglia M, Ismail HM, Atkinson MA, Philipson LH, Palmer JP, Evans-Molina C. Metabolic Markers Associated with Increased Risk for Progression from Single to Multiple Autoantibodies in Type 1 Diabetes Relatives Diabetes. 67. DOI: 10.2337/Db18-94-Or |
0.428 |
|
| 2018 |
WALKER AF, JOHNSON C, ANEZ-ZABALA C, DORVIL SR, HALLER MJ, GURKA MJ, BRUGGEMAN BS, GUIFFRE D, ATKINSON MA, SCHATZ I, SCHATZ D. A Content Analysis of Text Messages in a Type 1 Diabetes Peer Mentoring Program—The Importance of Shared Interests Diabetes. 67: 844-P. DOI: 10.2337/Db18-844-P |
0.357 |
|
| 2018 |
Campbell-Thompson M, Butterworth EA, Lenchik NI, Atkinson MA, Mathews CE, Gerling IC. Analysis of Transcriptome Data from 261 Individual Laser-Captured Islets from Nondiabetic, Autoantibody-Positive, and Type 1 Diabetic Organ Donors Diabetes. 67. DOI: 10.2337/Db18-308-Lb |
0.411 |
|
| 2018 |
Russell J, Roesch L, Atkinson MA, Schatz D, Triplett EW, Ludvigsson J. Genetic Risk for Type 1 Diabetes Profoundly Influences the Core Gut Microbiome in Children Diabetes. 67. DOI: 10.2337/Db18-209-Lb |
0.376 |
|
| 2018 |
SHAPIRO M, WASSERFALL C, SCHULTZ AR, MCGRAIL SM, HALLER MJ, SCHATZ D, ATKINSON MA, BRUSKO TM. Insulin-Like Growth-Factor Axis Collectively Identifies Pre–Type 1 Diabetes Diabetes. 67: 1967-P. DOI: 10.2337/Db18-1967-P |
0.637 |
|
| 2018 |
Campbell-Thompson M, Atkinson MA, Filipp SL, Gurka MJ, Beegle R, Schatz D, Haller MJ. Relative Pancreas Volume Is Reduced in Autoantibody Negative First-Degree Relatives and Subjects with Pre–Type 1 Diabetes Diabetes. 67. DOI: 10.2337/Db18-1816-P |
0.384 |
|
| 2018 |
Butterworth EA, Nasif LH, Nasif K, Carty KN, Mathews CE, Atkinson MA, Gerling IC, Campbell-Thompson M. Sympathetic Innervation of Human Alpha Cells Diabetes. 67. DOI: 10.2337/Db18-1799-P |
0.341 |
|
| 2018 |
Redondo MJ, Sosenko J, Libman I, Mcvean JJ, Atkinson MA, Becker DJ, Geyer S. Individuals with Single Islet Autoantibody Positivity (SA+) at Type 1 Diabetes (T1D) Diagnosis Have Distinct Characteristics Diabetes. 67. DOI: 10.2337/Db18-1691-P |
0.362 |
|
| 2018 |
ROSS JJ, WASSERFALL C, PERRY DJ, MCGRAIL KM, POSGAI AL, BRUSKO TM, SCHATZ D, HALLER MJ, ATKINSON MA. Exocrine Pancreatic Function as a Novel Biomarker in Pre-T1D Diabetes. 67: 1543-P. DOI: 10.2337/Db18-1543-P |
0.608 |
|
| 2018 |
ISMAIL HM, BECKER DJ, GEYER S, XU P, LIBMAN I, HEROLD KC, ATKINSON MA, REDONDO MJ, PALMER JP, SOSENKO J. Early and Later C-Peptide Responses during Oral Glucose Tolerance Testing (OGTT) Are Independently and Oppositely Predictive of Type 1 Diabetes (T1D) in Autoantibody-Positive (Ab+) Individuals Diabetes. 67: 1374-P. DOI: 10.2337/Db18-1374-P |
0.335 |
|
| 2018 |
WALKER AF, HALLER MJ, GURKA MJ, MORRIS HL, ANEZ-ZABALA C, BRUGGEMAN BS, GUIFFRE D, ROHRS H, ATKINSON MA, SCHATZ D. Promoting Health Equity in Type 1 Diabetes through Peer Mentorship—Findings from the All for ONE Randomized Controlled Trial Diabetes. 67: 1371-P. DOI: 10.2337/Db18-1371-P |
0.332 |
|
| 2017 |
Kusmartseva I, Beery M, Philips T, Selman S, Jadhav P, Wasserfall C, Muller A, Pugliese A, Longmate JA, Schatz DA, Atkinson MA, Kaddis JS. Hospital time prior to death and pancreas histopathology: implications for future studies. Diabetologia. PMID 29128936 DOI: 10.1007/S00125-017-4494-X |
0.353 |
|
| 2017 |
Wang Q, Racine JJ, Ratiu JJ, Wang S, Ettinger R, Wasserfall C, Atkinson MA, Serreze DV. Transient BAFF Blockade Inhibits Type 1 Diabetes Development in Nonobese Diabetic Mice by Enriching Immunoregulatory B Lymphocytes Sensitive to Deletion by Anti-CD20 Cotherapy. Journal of Immunology (Baltimore, Md. : 1950). PMID 29055002 DOI: 10.4049/Jimmunol.1700822 |
0.436 |
|
| 2017 |
Newman JRB, Conesa A, Mika M, New FN, Onengut-Gumuscu S, Atkinson MA, Rich SS, McIntyre LM, Concannon P. Disease-specific biases in alternative splicing and tissue-specific dysregulation revealed by multitissue profiling of lymphocyte gene expression in type 1 diabetes. Genome Research. PMID 29025893 DOI: 10.1101/Gr.217984.116 |
0.381 |
|
| 2017 |
Sanyoura M, Jacobsen L, Carmody D, Gaudio DD, Alkorta-Aranburu G, Arndt K, Hu YY, Kobiernicki F, Kusmartseva I, Atkinson MA, Philipson LH, Schatz D, Campbell-Thompson M, Greeley SAW. Pancreatic Histopathology of Human Monogenic Diabetes Due to Causal Variants in KCNJ11, HNF1A, GATA6, and LMNA. The Journal of Clinical Endocrinology and Metabolism. PMID 28938416 DOI: 10.1210/Jc.2017-01159 |
0.485 |
|
| 2017 |
Chen J, Chernatynskaya AV, Li JW, Kimbrell MR, Cassidy RJ, Perry DJ, Muir AB, Atkinson MA, Brusko TM, Mathews CE. T cells display mitochondria hyperpolarization in human type 1 diabetes. Scientific Reports. 7: 10835. PMID 28883439 DOI: 10.1038/S41598-017-11056-9 |
0.684 |
|
| 2017 |
Newby BN, Brusko TM, Zou B, Atkinson MA, Clare-Salzler M, Mathews CE. Type 1 Interferons Potentiate Human CD8(+) T Cell Cytotoxicity Through a STAT4 and Granzyme B Dependent Pathway. Diabetes. PMID 28877912 DOI: 10.2337/Db17-0106 |
0.649 |
|
| 2017 |
Wasserfall C, Nick HS, Campbell-Thompson M, Beachy D, Haataja L, Kusmartseva I, Posgai A, Beery M, Rhodes C, Bonifacio E, Arvan P, Atkinson M. Persistence of Pancreatic Insulin mRNA Expression and Proinsulin Protein in Type 1 Diabetes Pancreata. Cell Metabolism. 26: 568-575.e3. PMID 28877460 DOI: 10.1016/J.Cmet.2017.08.013 |
0.397 |
|
| 2017 |
Wan H, Merriman C, Atkinson MA, Wasserfall CH, Mcgrail KM, Liang Y, Fu D, Dai H. Proteoliposome-based full-length ZnT8 self-antigen for type 1 diabetes diagnosis on a plasmonic platform. Proceedings of the National Academy of Sciences of the United States of America. PMID 28874568 DOI: 10.1073/Pnas.1711169114 |
0.367 |
|
| 2017 |
Nathan BM, Boulware D, Geyer S, Atkinson MA, Colman P, Goland R, Russell W, Wentworth JM, Wilson DM, Evans-Molina C, Wherrett D, Skyler JS, Moran A, Sosenko JM. Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials. Diabetes Care. PMID 28860125 DOI: 10.2337/Dc17-0916 |
0.45 |
|
| 2017 |
O'Kell AL, Garrett TJ, Wasserfall C, Atkinson MA. Untargeted metabolomic analysis in naturally occurring canine diabetes mellitus identifies similarities to human Type 1 Diabetes. Scientific Reports. 7: 9467. PMID 28842637 DOI: 10.1038/S41598-017-09908-5 |
0.466 |
|
| 2017 |
Rodriguez-Calvo T, Atkinson M, Herrath MGv. Response to Comment on Rodriguez-Calvo et al. Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset. Diabetes 2017;66:1334-1345. Diabetes. 66. PMID 28830918 DOI: 10.2337/Dbi17-0029 |
0.466 |
|
| 2017 |
Yip L, Fuhlbrigge R, Atkinson MA, Fathman CG. Impact of blood collection and processing on peripheral blood gene expression profiling in type 1 diabetes. Bmc Genomics. 18: 636. PMID 28821222 DOI: 10.1186/S12864-017-3949-2 |
0.401 |
|
| 2017 |
Babon JAB, DeNicola ME, Blodgett DM, Crèvecoeur I, Buttrick TS, Maehr R, Bottino R, Naji A, Kaddis J, Elyaman W, James EA, Haliyur R, Brissova M, Overbergh L, Mathieu C, ... Atkinson MA, et al. Corrigendum: Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Nature Medicine. 23: 1004. PMID 28777787 DOI: 10.1038/nm0817-1004a |
0.37 |
|
| 2017 |
Haller M, Atkinson M, Schatz D. More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes. The New England Journal of Medicine. 377: 403-403. PMID 28748691 DOI: 10.1056/Nejmc1703468 |
0.473 |
|
| 2017 |
Rodriguez-Calvo T, Atkinson M, Herrath Mv. β-Cell mass versus function in type 1 diabetes mellitus: truth or dare? Nature Reviews Endocrinology. 13: 1-1. PMID 28685769 DOI: 10.1038/Nrendo.2017.83 |
0.461 |
|
| 2017 |
Jacobsen LM, Haller MJ, Parish A, Gurka MJ, Levine SR, Wasserfall C, Campbell-Thompson M, Kaddis J, Pugliese A, Atkinson MA, Schatz DA. High Illicit Drug Abuse and Suicide in Organ Donors With Type 1 Diabetes. Diabetes Care. PMID 28679687 DOI: 10.2337/Dc17-0996 |
0.411 |
|
| 2017 |
Marcial GE, Ford AL, Haller MJ, Gezan SA, Harrison NA, Cai D, Meyer JL, Perry DJ, Atkinson MA, Wasserfall CH, Garrett T, Gonzalez CF, Brusko TM, Dahl WJ, Lorca GL. Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults. Frontiers in Immunology. 8: 655. PMID 28659913 DOI: 10.3389/Fimmu.2017.00655 |
0.596 |
|
| 2017 |
O'Kell AL, Wasserfall C, Catchpole B, Davison LJ, Hess RS, Kushner JA, Atkinson MA. Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked? Diabetes. 66: 1443-1452. PMID 28533295 DOI: 10.2337/Db16-1551 |
0.515 |
|
| 2017 |
Atkinson MA, Nierras CR. Mary Tyler Moore (1936-2017): Diabetes Educator and Advocate. Diabetes Care. 40: 732-735. PMID 28533256 DOI: 10.2337/Dci17-0015 |
0.386 |
|
| 2017 |
Ratiu JJ, Racine JJ, Hasham MG, Wang Q, Branca JA, Chapman HD, Zhu J, Donghia N, Philip V, Schott WH, Wasserfall C, Atkinson MA, Mills KD, Leeth CM, Serreze DV. Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B Lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). PMID 28461573 DOI: 10.4049/Jimmunol.1700024 |
0.442 |
|
| 2017 |
Seay HR, Putnam AL, Cserny J, Posgai AL, Rosenau EH, Wingard JR, Girard KF, Kraus M, Lares AP, Brown HL, Brown KS, Balavage KT, Peters LD, Bushdorf AN, Atkinson MA, et al. Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy. Molecular Therapy. Methods & Clinical Development. 4: 178-191. PMID 28345003 DOI: 10.1016/J.Omtm.2016.12.003 |
0.685 |
|
| 2017 |
Posgai AL, Wasserfall CH, Kwon KC, Daniell H, Schatz DA, Atkinson MA. Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice. Scientific Reports. 7: 42372. PMID 28205558 DOI: 10.1038/Srep42372 |
0.444 |
|
| 2017 |
Babon JA, DeNicola ME, Blodgett DM, Crèvecoeur I, Buttrick TS, Maehr R, Bottino R, Naji A, Kaddis J, Elyaman W, James EA, Haliyur R, Brissova M, Overbergh L, Mathieu C, ... Atkinson MA, et al. Corrigendum: Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Nature Medicine. 23: 264. PMID 28170374 DOI: 10.1038/Nm0217-264A |
0.474 |
|
| 2017 |
Li X, Campbell-Thompson M, Wasserfall CH, McGrail K, Posgai A, Schultz AR, Brusko TM, Shuster J, Liang F, Muir A, Schatz D, Haller MJ, Atkinson MA. Serum Trypsinogen Levels in Type 1 Diabetes. Diabetes Care. PMID 28115475 DOI: 10.2337/Dc16-1774 |
0.679 |
|
| 2017 |
Campbell-Thompson ML, Atkinson MA, Butler AE, Giepmans BN, von Herrath MG, Hyöty H, Kay TW, Morgan NG, Powers AC, Pugliese A, Richardson SJ, In't Veld PA. Re-addressing the 2013 consensus guidelines for the diagnosis of insulitis in human type 1 diabetes: is change necessary? Diabetologia. PMID 28070616 DOI: 10.1007/S00125-016-4195-X |
0.442 |
|
| 2016 |
Ziegler AG, Bonifacio E, Powers AC, Todd JA, Harrison LC, Atkinson MA. Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease. Diabetes. 65: 3233-3239. PMID 27959859 DOI: 10.2337/Db16-0687 |
0.499 |
|
| 2016 |
Seay HR, Yusko E, Rothweiler SJ, Zhang L, Posgai AL, Campbell-Thompson M, Vignali M, Emerson RO, Kaddis JS, Ko D, Nakayama M, Smith MJ, Cambier JC, Pugliese A, Atkinson MA, et al. Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes. Jci Insight. 1: e88242. PMID 27942583 DOI: 10.1172/Jci.Insight.88242 |
0.647 |
|
| 2016 |
Michels AW, Landry LG, McDaniel KA, Yu L, Campbell-Thompson M, Kwok WW, Jones KL, Gottlieb PA, Kappler JW, Tang Q, Roep BO, Atkinson MA, Mathews CE, Nakayama M. Islet-derived CD4 T-cells targeting proinsulin in human autoimmune diabetes. Diabetes. PMID 27920090 DOI: 10.2337/Db16-1025 |
0.519 |
|
| 2016 |
Babon JA, DeNicola ME, Blodgett DM, Crèvecoeur I, Buttrick TS, Maehr R, Bottino R, Naji A, Kaddis J, Elyaman W, James EA, Haliyur R, Brissova M, Overbergh L, Mathieu C, ... ... Atkinson MA, et al. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Nature Medicine. PMID 27798614 DOI: 10.1038/Nm.4203 |
0.441 |
|
| 2016 |
Mahmoud TI, Wang J, Karnell JL, Wang Q, Wang S, Naiman B, Gross P, Brohawn PZ, Morehouse C, Aoyama J, Wasserfall C, Carter L, Atkinson MA, Serreze DV, Braley-Mullen H, et al. Autoimmune manifestations in aged mice arise from early-life immune dysregulation. Science Translational Medicine. 8: 361ra137. PMID 27798262 DOI: 10.1126/Scitranslmed.Aag0367 |
0.382 |
|
| 2016 |
Bonifacio E, Mathieu C, Nepom GT, Ziegler AG, Anhalt H, Haller MJ, Harrison LC, Hebrok M, Kushner JA, Norris JM, Peakman M, Powers AC, Todd JA, Atkinson MA. Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity. Diabetologia. PMID 27785529 DOI: 10.1007/S00125-016-4144-8 |
0.443 |
|
| 2016 |
Bian X, Wasserfall C, Wallstrom G, Wang J, Wang H, Barker K, Schatz D, Atkinson M, Qiu J, LaBaer J. Tracking the Antibody Immunome in Type 1 Diabetes Using Protein Arrays. Journal of Proteome Research. PMID 27690455 DOI: 10.1021/Acs.Jproteome.6B00354 |
0.438 |
|
| 2016 |
Haller MJ, Gitelman SE, Gottlieb PA, Michels AW, Perry DJ, Schultz AR, Hulme MA, Shuster JJ, Zou B, Wasserfall CH, Posgai A, Mathews CE, Brusko TM, Atkinson MA, Schatz DA. Anti-Thymocyte Globulin + G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders with Established Type 1 Diabetes. Diabetes. PMID 27669730 DOI: 10.2337/Db16-0823 |
0.625 |
|
| 2016 |
Richardson SJ, Rodriguez-Calvo T, Gerling IC, Mathews CE, Kaddis JS, Russell MA, Zeissler M, Leete P, Krogvold L, Dahl-Jørgensen K, von Herrath M, Pugliese A, Atkinson MA, Morgan NG. Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes. Diabetologia. PMID 27506584 DOI: 10.1007/S00125-016-4067-4 |
0.445 |
|
| 2016 |
Burke GW, Posgai AL, Wasserfall CH, Atkinson MA, Pugliese A. Raising Awareness: The Need to Promote Allocation of Pancreata from Rare Non-Diabetic Donors with Pancreatic Islet Autoimmunity to Type 1 Diabetes Research. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 27460917 DOI: 10.1111/Ajt.13983 |
0.455 |
|
| 2016 |
Jacobsen LM, Atkinson MA, Campbell-Thompson M, Schatz DA. Presumptive Type 1 Diabetes With Comorbidities and Rapid Progression Despite Numerous Insulin-Positive Islets. Diabetes Care. 39: 1292-4. PMID 27330131 DOI: 10.2337/Dc16-0737 |
0.475 |
|
| 2016 |
Endesfelder D, Engel M, Davis-Richardson AG, Ardissone AN, Achenbach P, Hummel S, Winkler C, Atkinson M, Schatz D, Triplett E, Ziegler AG, zu Castell W. Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production. Microbiome. 4: 17. PMID 27114075 DOI: 10.1186/S40168-016-0163-4 |
0.435 |
|
| 2016 |
Wasserfall C, Montgomery E, Yu L, Michels A, Gianani R, Pugliese A, Nierras C, Kaddis JS, Schatz DA, Bonifacio E, Atkinson MA. Validation of a Rapid Type 1 Diabetes Autoantibody Screening Assay for Community Based Screening of Organ Donors to Identify Subjects at Increased Risk for the Disease. Clinical and Experimental Immunology. PMID 27029857 DOI: 10.1111/Cei.12797 |
0.412 |
|
| 2016 |
Liu CW, Atkinson MA, Zhang Q. Type 1 Diabetes Cadaveric Human Pancreata Exhibit a Unique Exocrine Tissue Proteomic Profile. Proteomics. PMID 26935967 DOI: 10.1002/Pmic.201500333 |
0.413 |
|
| 2016 |
Campbell-Thompson ML, Schatz DA, Kaddis JS, Atkinson MA. Pancreatic duct hyperplasia/dysplasia in type 1 diabetes and pancreatic weight in individuals with and without diabetes. Reply to Kobayashi T, Aida K, Fukui T et al [letter] and Saisho Y [letter]. Diabetologia. 59: 870-2. PMID 26861059 DOI: 10.1007/S00125-016-3889-4 |
0.428 |
|
| 2016 |
von Herrath MG, Korsgren O, Atkinson MA. Factors impeding the discovery of an intervention-based treatment for type 1 diabetes Clinical and Experimental Immunology. 183: 1-7. DOI: 10.1111/Cei.12656 |
0.399 |
|
| 2016 |
Campbell-Thompson ML, Schatz DA, Kaddis JS, Atkinson MA. Pancreatic duct hyperplasia/dysplasia in type 1 diabetes and pancreatic weight in individuals with and without diabetes. Reply to Kobayashi T, Aida K, Fukui T et al [letter] and Saisho Y [letter] Diabetologia. 59: 870-872. DOI: 10.1007/s00125-016-3889-4 |
0.315 |
|
| 2015 |
Gill RG, Pagni PP, Kufper T, Wasserfall CH, Deng S, Posgai A, Manenkova Y, Hani AB, Straub L, Bernstein P, Atkinson MA, Herold KC, von Herrath M, Staeva T, Ehlers MR, et al. A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice. Diabetes. PMID 26718498 DOI: 10.2337/Db15-0492 |
0.409 |
|
| 2015 |
Campbell-Thompson M, Fu A, Kaddis JS, Wasserfall C, Schatz DA, Pugliese A, Atkinson MA. Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes. Diabetes. PMID 26581594 DOI: 10.2337/Db15-0779 |
0.515 |
|
| 2015 |
Gagliani N, Jofra T, Posgai AL, Atkinson MA, Battaglia M. Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice. Plos One. 10: e0142318. PMID 26580221 DOI: 10.1371/Journal.Pone.0142318 |
0.491 |
|
| 2015 |
Jurczyk A, Nowosielska A, Przewozniak N, Aryee KE, DiIorio P, Blodgett D, Yang C, Campbell-Thompson M, Atkinson M, Shultz L, Rittenhouse A, Harlan D, Greiner D, Bortell R. Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic β-cell function via glycogen synthase kinase-3β. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 26546129 DOI: 10.1096/Fj.15-279810 |
0.332 |
|
| 2015 |
Garrigan E, Belkin NS, Seydel F, Han Z, Carter J, McDuffie M, Morel L, Peck AB, Clare-Salzler MJ, Atkinson M, Wasserfall C, Davoodi-Semiromi A, Shi JD, Haskell-Luevano C, Yang LJ, et al. Csf2 and Ptgs2 Epigenetic Dysregulation in Diabetes-prone Bicongenic B6.NODC11bxC1tb Mice. Genetics & Epigenetics. 7: 5-17. PMID 26512207 DOI: 10.4137/GEG.S29696 |
0.338 |
|
| 2015 |
Haller MJ, Atkinson MA, Wasserfall CH, Brusko TM, Mathews CE, Hulme M, Cintron M, Shuster J, McGrail K, Posgai A, Schatz D. Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes. Clinical and Experimental Immunology. PMID 26462724 DOI: 10.1111/Cei.12731 |
0.645 |
|
| 2015 |
Bian X, Wallstrom G, Davis A, Wang J, Park J, Throop A, Steel J, Yu X, Wasserfall C, Schatz D, Atkinson M, Qiu J, LaBaer J. Immunoproteomic Profiling of Anti-Viral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays. Diabetes. PMID 26450993 DOI: 10.2337/Db15-0179 |
0.328 |
|
| 2015 |
Insel RA, Dunne JL, Atkinson MA, Chiang JL, Dabelea D, Gottlieb PA, Greenbaum CJ, Herold KC, Krischer JP, Lernmark Å, Ratner RE, Rewers MJ, Schatz DA, Skyler JS, Sosenko JM, et al. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 38: 1964-74. PMID 26404926 DOI: 10.2337/Dc15-1419 |
0.452 |
|
| 2015 |
Campbell-Thompson ML, Kaddis JS, Wasserfall C, Haller MJ, Pugliese A, Schatz DA, Shuster JJ, Atkinson MA. The influence of type 1 diabetes on pancreatic weight. Diabetologia. PMID 26358584 DOI: 10.1007/S00125-015-3752-Z |
0.461 |
|
| 2015 |
Yoon YM, Lewis JS, Carstens MR, Campbell-Thompson M, Wasserfall CH, Atkinson MA, Keselowsky BG. A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice. Scientific Reports. 5: 13155. PMID 26279095 DOI: 10.1038/Srep13155 |
0.427 |
|
| 2015 |
Li X, Atkinson MA. The role for gut permeability in the pathogenesis of type 1 diabetes--a solid or leaky concept? Pediatric Diabetes. 16: 485-92. PMID 26269193 DOI: 10.1111/Pedi.12305 |
0.437 |
|
| 2015 |
Mathews CE, Xue S, Posgai A, Lightfoot YL, Li X, Lin A, Wasserfall C, Haller MJ, Schatz D, Atkinson MA. Acute Versus Progressive Onset of Diabetes in NOD Mice - Potential Implications for Therapeutic Interventions in Type 1 Diabetes. Diabetes. PMID 26216853 DOI: 10.2337/Db15-0449 |
0.493 |
|
| 2015 |
Xue S, Posgai A, Wasserfall C, Myhr C, Campbell-Thompson M, Mathews CE, Brusko T, Rabinovitch A, Savinov A, Battaglia M, Schatz D, Haller M, Atkinson M. Combination therapy reverses hyperglycemia in NOD mice with established type 1 diabetes. Diabetes. PMID 26185279 DOI: 10.2337/Db15-0164 |
0.665 |
|
| 2015 |
Kaddis JS, Pugliese A, Atkinson MA. A run on the biobank: what have we learned about type 1 diabetes from the nPOD tissue repository? Current Opinion in Endocrinology, Diabetes, and Obesity. 22: 290-5. PMID 26087339 DOI: 10.1097/Med.0000000000000171 |
0.463 |
|
| 2015 |
Atkinson MA, von Herrath M, Powers AC, Clare-Salzler M. Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease. Diabetes Care. 38: 979-88. PMID 25998290 DOI: 10.2337/Dc15-0144 |
0.501 |
|
| 2015 |
Fuhrman CA, Yeh WI, Seay HR, Saikumar Lakshmi P, Chopra G, Zhang L, Perry DJ, McClymont SA, Yadav M, Lopez MC, Baker HV, Zhang Y, Li Y, Whitley M, von Schack D, ... Atkinson MA, et al. Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226. Journal of Immunology (Baltimore, Md. : 1950). 195: 145-55. PMID 25994968 DOI: 10.4049/Jimmunol.1402381 |
0.675 |
|
| 2015 |
Lewis JS, Dolgova NV, Zhang Y, Xia CQ, Wasserfall CH, Atkinson MA, Clare-Salzler MJ, Keselowsky BG. A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice. Clinical Immunology (Orlando, Fla.). PMID 25842187 DOI: 10.1016/J.Clim.2015.03.023 |
0.437 |
|
| 2015 |
Battaglia M, Atkinson MA. The streetlight effect in type 1 diabetes. Diabetes. 64: 1081-90. PMID 25805758 DOI: 10.2337/Db14-1208 |
0.401 |
|
| 2015 |
Poudel A, Savari O, Striegel DA, Periwal V, Taxy J, Millis JM, Witkowski P, Atkinson MA, Hara M. Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes. Endocrine. 49: 693-702. PMID 25605478 DOI: 10.1007/S12020-015-0534-9 |
0.353 |
|
| 2015 |
Kemppainen KM, Ardissone AN, Davis-Richardson AG, Fagen JR, Gano KA, León-Novelo LG, Vehik K, Casella G, Simell O, Ziegler AG, Rewers MJ, Lernmark Å, Hagopian W, She JX, Krischer JP, ... Atkinson MA, et al. Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes. Diabetes Care. 38: 329-32. PMID 25519450 DOI: 10.2337/Dc14-0850 |
0.458 |
|
| 2015 |
Haller MJ, Gitelman SE, Gottlieb PA, Michels AW, Rosenthal SM, Shuster JJ, Zou B, Brusko TM, Hulme MA, Wasserfall CH, Mathews CE, Atkinson MA, Schatz DA. Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes. The Journal of Clinical Investigation. 125: 448-55. PMID 25500887 DOI: 10.1172/Jci78492 |
0.651 |
|
| 2015 |
Kleffel S, Vergani A, Tezza S, Ben Nasr M, Niewczas MA, Wong S, Bassi R, D'Addio F, Schatton T, Abdi R, Atkinson M, Sayegh MH, Wen L, Wasserfall CH, O'Connor KC, et al. Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens. Diabetes. 64: 158-71. PMID 25187361 DOI: 10.2337/Db13-1639 |
0.455 |
|
| 2014 |
Davis-Richardson AG, Ardissone AN, Dias R, Simell V, Leonard MT, Kemppainen KM, Drew JC, Schatz D, Atkinson MA, Kolaczkowski B, Ilonen J, Knip M, Toppari J, Nurminen N, Hyöty H, et al. Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Frontiers in Microbiology. 5: 678. PMID 25540641 DOI: 10.3389/Fmicb.2014.00678 |
0.35 |
|
| 2014 |
Kushner JA, MacDonald PE, Atkinson MA. Stem cells to insulin secreting cells: two steps forward and now a time to pause? Cell Stem Cell. 15: 535-6. PMID 25517460 DOI: 10.1016/J.Stem.2014.10.012 |
0.387 |
|
| 2014 |
Atkinson MA. Losing a grip on the notion of β-cell specificity for immune responses in type 1 diabetes: can we handle the truth? Diabetes. 63: 3572-4. PMID 25342726 DOI: 10.2337/Db14-1069 |
0.482 |
|
| 2014 |
Pugliese A, Vendrame F, Reijonen H, Atkinson MA, Campbell-Thompson M, Burke GW. New insight on human type 1 diabetes biology: nPOD and nPOD-transplantation Current Diabetes Reports. 14: 530. PMID 25142715 DOI: 10.1007/S11892-014-0530-0 |
0.438 |
|
| 2014 |
Purwana I, Zheng J, Li X, Deurloo M, Son DO, Zhang Z, Liang C, Shen E, Tadkase A, Feng ZP, Li Y, Hasilo C, Paraskevas S, Bortell R, Greiner DL, Atkinson M, et al. GABA promotes human β-cell proliferation and modulates glucose homeostasis. Diabetes. 63: 4197-205. PMID 25008178 DOI: 10.2337/Db14-0153 |
0.316 |
|
| 2014 |
Xia CQ, Peng R, Chernatynskaya AV, Yuan L, Carter C, Valentine J, Sobel E, Atkinson MA, Clare-Salzler MJ. Increased IFN-α-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-α production. Journal of Immunology (Baltimore, Md. : 1950). 193: 1024-34. PMID 24973447 DOI: 10.4049/Jimmunol.1303230 |
0.386 |
|
| 2014 |
Radichev IA, Maneva-Radicheva LV, Amatya C, Parker C, Ellefson J, Wasserfall C, Atkinson M, Burn P, Savinov AY. Nardilysin-dependent proteolysis of cell-associated VTCN1 (B7-H4) marks type 1 diabetes development. Diabetes. 63: 3470-82. PMID 24848066 DOI: 10.2337/Db14-0213 |
0.497 |
|
| 2014 |
Lewis JS, Roche C, Zhang Y, Brusko TM, Wasserfall CH, Atkinson M, Clare-Salzler MJ, Keselowsky BG. Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres. Journal of Materials Chemistry. B, Materials For Biology and Medicine. 2: 2562-2574. PMID 24778809 DOI: 10.1039/C3Tb21460E |
0.59 |
|
| 2014 |
Robert S, Gysemans C, Takiishi T, Korf H, Spagnuolo I, Sebastiani G, Van Huynegem K, Steidler L, Caluwaerts S, Demetter P, Wasserfall CH, Atkinson MA, Dotta F, Rottiers P, Van Belle TL, et al. Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. Diabetes. 63: 2876-87. PMID 24677716 DOI: 10.2337/Db13-1236 |
0.474 |
|
| 2014 |
Dunne JL, Triplett EW, Gevers D, Xavier R, Insel R, Danska J, Atkinson MA. The intestinal microbiome in type 1 diabetes. Clinical and Experimental Immunology. 177: 30-7. PMID 24628412 DOI: 10.1111/Cei.12321 |
0.446 |
|
| 2014 |
Endesfelder D, zu Castell W, Ardissone A, Davis-Richardson AG, Achenbach P, Hagen M, Pflueger M, Gano KA, Fagen JR, Drew JC, Brown CT, Kolaczkowski B, Atkinson M, Schatz D, Bonifacio E, et al. Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes. 63: 2006-14. PMID 24608442 DOI: 10.2337/Db13-1676 |
0.407 |
|
| 2014 |
Atkinson MA. Pancreatic biopsies in type 1 diabetes: revisiting the myth of Pandora's box. Diabetologia. 57: 656-9. PMID 24442510 DOI: 10.1007/S00125-013-3159-7 |
0.454 |
|
| 2014 |
Pugliese A, Yang M, Kusmarteva I, Heiple T, Vendrame F, Wasserfall C, Rowe P, Moraski JM, Ball S, Jebson L, Schatz DA, Gianani R, Burke GW, Nierras C, Staeva T, ... ... Atkinson MA, et al. The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: Goals, operational model and emerging findings Pediatric Diabetes. 15: 1-9. PMID 24325575 DOI: 10.1111/Pedi.12097 |
0.418 |
|
| 2014 |
Giannopoulou EZ, Puff R, Beyerlein A, von Luettichau I, Boerschmann H, Schatz D, Atkinson M, Haller MJ, Egger D, Burdach S, Ziegler AG. Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: a non-randomized, controlled trial. Pediatric Diabetes. 15: 100-9. PMID 24102806 DOI: 10.1111/Pedi.12072 |
0.416 |
|
| 2014 |
Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet (London, England). 383: 69-82. PMID 23890997 DOI: 10.1016/S0140-6736(13)60591-7 |
0.492 |
|
| 2014 |
Guleria I, Bupp MG, Dada S, Fife BT, Tang Q, Ansari MJ, Trikudanathan S, Vadivel N, Fiorina P, Yagita H, Azuma M, Atkinson M, Bluestone JA, Sayegh MH. Corrigendum to 'Mechanisms of PDL1-mediated regulation of autoimmune diabetes' [Clin. Immunol. 125 (2007) 16-25] Clinical Immunology. 150: 134. DOI: 10.1016/J.Clim.2013.09.004 |
0.572 |
|
| 2013 |
Atkinson MA. Trying to make a difference for those with Type 1 diabetes: a lesson in patience as well as a willingness to fail mightily. Expert Review of Endocrinology & Metabolism. 8: 323-327. PMID 30736146 DOI: 10.1586/17446651.2013.811869 |
0.504 |
|
| 2013 |
Atkinson MA, Ogle GD. Improving diabetes care in resource-poor countries: challenges and opportunities. The Lancet. Diabetes & Endocrinology. 1: 268-70. PMID 24622408 DOI: 10.1016/S2213-8587(13)70172-4 |
0.381 |
|
| 2013 |
Garrigan E, Belkin NS, Alexander JJ, Han Z, Seydel F, Carter J, Atkinson M, Wasserfall C, Clare-Salzler MJ, Amick MA, Litherland SA. Persistent STAT5 phosphorylation and epigenetic dysregulation of GM-CSF and PGS2/COX2 expression in Type 1 diabetic human monocytes. Plos One. 8: e76919. PMID 24204704 DOI: 10.1371/Journal.Pone.0076919 |
0.318 |
|
| 2013 |
Miersch S, Bian X, Wallstrom G, Sibani S, Logvinenko T, Wasserfall CH, Schatz D, Atkinson M, Qiu J, LaBaer J. Serological autoantibody profiling of type 1 diabetes by protein arrays. Journal of Proteomics. 94: 486-96. PMID 24148850 DOI: 10.1016/J.Jprot.2013.10.018 |
0.376 |
|
| 2013 |
Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC. Response to comments on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:2595-2604. Diabetes. 62: e19-22. PMID 24065800 DOI: 10.2337/Db13-0996 |
0.434 |
|
| 2013 |
Rowe P, Wasserfall C, Croker B, Campbell-Thompson M, Pugliese A, Atkinson M, Schatz D. Increased Complement Activation in Human Type 1 Diabetes Pancreata Diabetes Care. 36: 3815-3817. PMID 24041678 DOI: 10.2337/Dc13-0203 |
0.452 |
|
| 2013 |
Campbell-Thompson ML, Atkinson MA, Butler AE, Chapman NM, Frisk G, Gianani R, Giepmans BN, von Herrath MG, Hyöty H, Kay TW, Korsgren O, Morgan NG, Powers AC, Pugliese A, Richardson SJ, et al. The diagnosis of insulitis in human type 1 diabetes. Diabetologia. 56: 2541-3. PMID 24006089 DOI: 10.1007/S00125-013-3043-5 |
0.466 |
|
| 2013 |
Tian J, Dang H, Chen Z, Guan A, Jin Y, Atkinson MA, Kaufman DL. γ-Aminobutyric acid regulates both the survival and replication of human β-cells. Diabetes. 62: 3760-5. PMID 23995958 DOI: 10.2337/Db13-0931 |
0.307 |
|
| 2013 |
Beran D, Yudkin JS, Atkinson MA. Global reality of type 1 diabetes care in 2013. Diabetes Care. 36: e144. PMID 23970723 DOI: 10.2337/Dc13-0744 |
0.424 |
|
| 2013 |
Myhr CB, Hulme MA, Wasserfall CH, Hong PJ, Lakshmi PS, Schatz DA, Haller MJ, Brusko TM, Atkinson MA. The autoimmune disease-associated SNP rs917997 of IL18RAP controls IFNγ production by PBMC. Journal of Autoimmunity. 44: 8-12. PMID 23891168 DOI: 10.1016/J.Jaut.2013.06.001 |
0.59 |
|
| 2013 |
Villalta SA, Lang J, Kubeck S, Kabre B, Szot GL, Calderon B, Wasserfall C, Atkinson MA, Brekken RA, Pullen N, Arch RH, Bluestone JA. Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function. Diabetes. 62: 2870-8. PMID 23835340 DOI: 10.2337/Db12-1619 |
0.607 |
|
| 2013 |
Gagliani N, Jofra T, Valle A, Stabilini A, Morsiani C, Gregori S, Deng S, Rothstein DM, Atkinson M, Kamanaka M, Flavell RA, Roncarolo MG, Battaglia M. Transplant tolerance to pancreatic islets is initiated in the graft and sustained in the spleen. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 13: 1963-75. PMID 23834659 DOI: 10.1111/Ajt.12333 |
0.38 |
|
| 2013 |
Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, McGrail KM, Wingard JR, Theriaque DW, Shuster JJ, Ferguson RJ, Kozuch M, Clare-Salzler M, Atkinson MA, Schatz DA. Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1126-9. PMID 23611977 DOI: 10.1016/J.Bbmt.2013.04.011 |
0.632 |
|
| 2013 |
Tang DQ, Shun L, Koya V, Sun Y, Wang Q, Wang H, Li SW, Sun Y, Purich DL, Zhang C, Hansen B, Qian K, Atkinson M, Phillips MI, Yang LJ. Genetically reprogrammed, liver-derived insulin-producing cells are glucose-responsive, but susceptible to autoimmune destruction in settings of murine model of type 1 diabetes. American Journal of Translational Research. 5: 184-99. PMID 23573363 |
0.341 |
|
| 2013 |
Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes. 62: 2595-604. PMID 23524641 DOI: 10.2337/Db12-1686 |
0.361 |
|
| 2013 |
Sarikonda G, Sachithanantham S, Manenkova Y, Kupfer T, Posgai A, Wasserfall C, Bernstein P, Straub L, Pagni PP, Schneider D, Calvo TR, Coulombe M, Herold K, Gill RG, Atkinson M, et al. Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice. Plos One. 8: e54712. PMID 23405091 DOI: 10.1371/Journal.Pone.0054712 |
0.449 |
|
| 2013 |
Zhang Q, Fillmore TL, Schepmoes AA, Clauss TR, Gritsenko MA, Mueller PW, Rewers M, Atkinson MA, Smith RD, Metz TO. Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes. The Journal of Experimental Medicine. 210: 191-203. PMID 23277452 DOI: 10.1084/Jem.20111843 |
0.468 |
|
| 2013 |
Staeva TP, Chatenoud L, Insel R, Atkinson MA. Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials. Diabetes. 62: 9-17. PMID 23258904 DOI: 10.2337/Db12-0562 |
0.398 |
|
| 2013 |
Cabrera R, Ararat M, Xu Y, Brusko T, Wasserfall C, Atkinson MA, Chang LJ, Liu C, Nelson DR. Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma. Cancer Immunology, Immunotherapy : Cii. 62: 737-46. PMID 23223899 DOI: 10.1007/S00262-012-1380-8 |
0.599 |
|
| 2013 |
Davoodi-Semiromi A, Wasserfall CH, Hassanzadeh A, Cooper-DeHoff RM, Wabitsch M, Atkinson M. Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes. Immunogenetics. 65: 83-90. PMID 23081744 DOI: 10.1007/S00251-012-0659-4 |
0.432 |
|
| 2013 |
Atkinson MA. Trying to make a difference for those with Type 1 diabetes: A lesson in patience as well as a willingness to fail mightily Expert Review of Endocrinology and Metabolism. 8: 323-327. DOI: 10.1586/17446651.2013.811869 |
0.377 |
|
| 2013 |
Pugliese A, Campbell-Thompson M, Staeva T, Atkinson MA. The JDRF network for the pancreatic organ donor with diabetes (nPOD): A novel resource and study approach in type 1 diabetes research Diabetes and Viruses. 2147483647: 245-255. DOI: 10.1007/978-1-4614-4051-2_24 |
0.37 |
|
| 2012 |
Xia CQ, Chernatynskaya AV, Wasserfall CH, Wan S, Looney BM, Eisenbeis S, Williams J, Clare-Salzler MJ, Atkinson MA. Anti-thymocyte globulin (ATG) differentially depletes naïve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice. Bmc Immunology. 13: 70. PMID 23237483 DOI: 10.1186/1471-2172-13-70 |
0.375 |
|
| 2012 |
Campbell-Thompson M, Wasserfall C, Montgomery EL, Atkinson MA, Kaddis JS. Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes. Jama. 308: 2337-9. PMID 23232891 DOI: 10.1001/Jama.2012.15008 |
0.419 |
|
| 2012 |
Cabrera R, Fitian AI, Ararat M, Xu Y, Brusko T, Wasserfall C, Atkinson MA, Liu C, Nelson DR. Serum levels of soluble CD25 as a marker for hepatocellular carcinoma. Oncology Letters. 4: 840-846. PMID 23205111 DOI: 10.3892/Ol.2012.826 |
0.531 |
|
| 2012 |
Beran D, Basey M, Wirtz V, Kaplan W, Atkinson M, Yudkin JS. On the road to the insulin centenary. Lancet (London, England). 380: 1648. PMID 23141616 DOI: 10.1016/S0140-6736(12)61950-3 |
0.374 |
|
| 2012 |
Atkinson MA. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harbor Perspectives in Medicine. 2. PMID 23125199 DOI: 10.1101/Cshperspect.A007641 |
0.474 |
|
| 2012 |
Atkinson MA, Chervonsky A. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease Diabetologia. 55: 2868-2877. PMID 22875196 DOI: 10.1007/S00125-012-2672-4 |
0.44 |
|
| 2012 |
Tang DQ, Wang Q, Burkhardt BR, Litherland SA, Atkinson MA, Yang LJ. In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long-term culture running risk of malignant transformation. American Journal of Stem Cells. 1: 114-127. PMID 22833839 |
0.301 |
|
| 2012 |
Gregg BE, Moore PC, Demozay D, Hall BA, Li M, Husain A, Wright AJ, Atkinson MA, Rhodes CJ. Formation of a human β-cell population within pancreatic islets is set early in life. The Journal of Clinical Endocrinology and Metabolism. 97: 3197-206. PMID 22745242 DOI: 10.1210/Jc.2012-1206 |
0.382 |
|
| 2012 |
Campbell-Thompson ML, Montgomery EL, Foss RM, Kolheffer KM, Phipps G, Schneider L, Atkinson MA. Collection protocol for human pancreas. Journal of Visualized Experiments : Jove. e4039. PMID 22665046 DOI: 10.3791/4039 |
0.349 |
|
| 2012 |
Davoodi-Semiromi A, Hassanzadeh A, Wasserfall CH, Droney A, Atkinson M. Tyrphostin AG490 agent modestly but significantly prevents onset of type 1 in NOD mouse; implication of immunologic and metabolic effects of a Jak-Stat pathway inhibitor. Journal of Clinical Immunology. 32: 1038-1047. PMID 22661285 DOI: 10.1007/S10875-012-9707-Y |
0.374 |
|
| 2012 |
Davoodi-Semiromi A, Wasserfall CH, Xia CQ, Cooper-DeHoff RM, Wabitsch M, Clare-Salzler M, Atkinson M. The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD mice. Plos One. 7: e36079. PMID 22615750 DOI: 10.1371/Journal.Pone.0036079 |
0.474 |
|
| 2012 |
Campbell-Thompson M, Wasserfall C, Kaddis J, Albanese-O'Neill A, Staeva T, Nierras C, Moraski J, Rowe P, Gianani R, Eisenbarth G, Crawford J, Schatz D, Pugliese A, Atkinson M. Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes/Metabolism Research and Reviews. 28: 608-17. PMID 22585677 DOI: 10.1002/Dmrr.2316 |
0.445 |
|
| 2012 |
Wang M, Racine JJ, Song X, Li X, Nair I, Liu H, Avakian-Mansoorian A, Johnston HF, Liu C, Shen C, Atkinson M, Todorov I, Kandeel F, Forman S, Wilson B, et al. Mixed chimerism and growth factors augment β cell regeneration and reverse late-stage type 1 diabetes. Science Translational Medicine. 4: 133ra59. PMID 22572882 DOI: 10.1126/Scitranslmed.3003835 |
0.444 |
|
| 2012 |
Takiishi T, Korf H, Van Belle TL, Robert S, Grieco FA, Caluwaerts S, Galleri L, Spagnuolo I, Steidler L, Van Huynegem K, Demetter P, Wasserfall C, Atkinson MA, Dotta F, Rottiers P, et al. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. The Journal of Clinical Investigation. 122: 1717-25. PMID 22484814 DOI: 10.1089/Dia.2013.1510 |
0.511 |
|
| 2012 |
Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, Roep BO, von Herrath MG. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. The Journal of Experimental Medicine. 209: 51-60. PMID 22213807 DOI: 10.1084/Jem.20111187 |
0.482 |
|
| 2012 |
Hulme MA, Wasserfall CH, Atkinson MA, Brusko TM. Central role for interleukin-2 in type 1 diabetes. Diabetes. 61: 14-22. PMID 22187370 DOI: 10.2337/Db11-1213 |
0.688 |
|
| 2012 |
Atkinson MA, Bluestone JA, Eisenbarth GS, Hebrok M, Herold KC, Accili D, Pietropaolo M, Arvan PR, Von Herrath M, Markel DS, Rhodes CJ. How does type 1 diabetes develop? The notion of homicide or β-cell suicide revisited (Diabetes (2011) 60, (1370-1379)) Diabetes. 61: 1648. DOI: 10.2337/Db12-Er06A |
0.641 |
|
| 2012 |
Xia C, Chernatynskaya A, Wasserfall C, Looney B, Wan S, Clare-Salzler M, Atkinson M. Anti-Thymocyte Globulin (ATG) Differentially Depletes naïve and Memory T Cells and Permits Memory-Type Regulatory T Cells Blood. 120: 4670-4670. DOI: 10.1182/Blood.V120.21.4670.4670 |
0.379 |
|
| 2011 |
Ararat MA, Fitian AI, Brusko T, Xu Y, Wasserfall C, Atkinson M, Liu C, Allegra CJ, Nelson D, Cabrera R. The soluble form of the IL-2 receptor (sCD25) as a novel biomarker for hepatocellular carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e14629. PMID 28021352 DOI: 10.1200/Jco.2011.29.15_Suppl.E14629 |
0.537 |
|
| 2011 |
Gagliani N, Gregori S, Jofra T, Valle A, Stabilini A, Rothstein DM, Atkinson M, Roncarolo MG, Battaglia M. Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation. Plos One. 6: e28434. PMID 22174806 DOI: 10.1371/Journal.Pone.0028434 |
0.345 |
|
| 2011 |
Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, Casella G, Drew JC, Ilonen J, Knip M, Hyöty H, Veijola R, Simell T, Simell O, Neu J, ... ... Atkinson MA, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. Plos One. 6: e25792. PMID 22043294 DOI: 10.1371/Journal.Pone.0025792 |
0.357 |
|
| 2011 |
Michels AW, Ostrov DA, Zhang L, Nakayama M, Fuse M, McDaniel K, Roep BO, Gottlieb PA, Atkinson MA, Eisenbarth GS. Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation. Journal of Immunology (Baltimore, Md. : 1950). 187: 5921-30. PMID 22043012 DOI: 10.4049/Jimmunol.1100746 |
0.412 |
|
| 2011 |
Schatz DA, Levine SR, Atkinson MA. It's time to mow the GRAS in type 1 diabetes. Diabetes. 60: 2669-71. PMID 22025772 DOI: 10.2337/Db11-1158 |
0.432 |
|
| 2011 |
Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, McGrail KM, Sumrall TM, Wingard JR, Theriaque DW, Shuster JJ, Atkinson MA, Schatz DA. Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide. Diabetes Care. 34: 2567-9. PMID 22011412 DOI: 10.2337/Dc11-1406 |
0.636 |
|
| 2011 |
Diiorio P, Jurczyk A, Yang C, Racki WJ, Brehm MA, Atkinson MA, Powers AC, Shultz LD, Greiner DL, Bortell R. Hyperglycemia-induced proliferation of adult human beta cells engrafted into spontaneously diabetic immunodeficient NOD-Rag1null IL2rγnull Ins2Akita mice. Pancreas. 40: 1147-9. PMID 21926555 DOI: 10.1097/Mpa.0B013E31821Ffabe |
0.413 |
|
| 2011 |
Serreze DV, Chapman HD, Niens M, Dunn R, Kehry MR, Driver JP, Haller M, Wasserfall C, Atkinson MA. Loss of intra-islet CD20 expression may complicate efficacy of B-cell-directed type 1 diabetes therapies. Diabetes. 60: 2914-21. PMID 21926271 DOI: 10.2337/Db11-0705 |
0.503 |
|
| 2011 |
Atkinson MA. Evaluating preclinical efficacy. Science Translational Medicine. 3: 96cm22. PMID 21849661 DOI: 10.1126/Scitranslmed.3002757 |
0.4 |
|
| 2011 |
Blanton D, Han Z, Bierschenk L, Linga-Reddy MV, Wang H, Clare-Salzler M, Haller M, Schatz D, Myhr C, She JX, Wasserfall C, Atkinson M. Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes. Diabetes. 60: 2566-70. PMID 21844098 DOI: 10.2337/Db11-0576 |
0.409 |
|
| 2011 |
Wasserfall C, Nead K, Mathews C, Atkinson MA. The threshold hypothesis: Solving the equation of nurture vs nature in type 1 diabetes Diabetologia. 54: 2232-2236. PMID 21773685 DOI: 10.1007/S00125-011-2244-Z |
0.44 |
|
| 2011 |
Kelly-Scumpia KM, Scumpia PO, Weinstein JS, Delano MJ, Cuenca AG, Nacionales DC, Wynn JL, Lee PY, Kumagai Y, Efron PA, Akira S, Wasserfall C, Atkinson MA, Moldawer LL. B cells enhance early innate immune responses during bacterial sepsis. The Journal of Experimental Medicine. 208: 1673-82. PMID 21746813 DOI: 10.1084/Jem.20101715 |
0.346 |
|
| 2011 |
Ize-Ludlow D, Lightfoot YL, Parker M, Xue S, Wasserfall C, Haller MJ, Schatz D, Becker DJ, Atkinson MA, Mathews CE. Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes. Diabetes. 60: 2086-91. PMID 21659497 DOI: 10.2337/Db11-0373 |
0.509 |
|
| 2011 |
Atkinson MA, Bluestone JA, Eisenbarth GS, Hebrok M, Herold KC, Accili D, Pietropaolo M, Arvan PR, Von Herrath M, Markel DS, Rhodes CJ. How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited. Diabetes. 60: 1370-9. PMID 21525508 DOI: 10.2337/Db10-1797 |
0.595 |
|
| 2011 |
Yong J, Rasooly J, Dang H, Lu Y, Middleton B, Zhang Z, Hon L, Namavari M, Stout DB, Atkinson MA, Tian J, Gambhir SS, Kaufman DL. Multimodality imaging of β-cells in mouse models of type 1 and 2 diabetes. Diabetes. 60: 1383-92. PMID 21441442 DOI: 10.2337/Db10-0907 |
0.366 |
|
| 2011 |
Greenbaum C, Atkinson MA. Persistence is the twin sister of excellence: an important lesson for attempts to prevent and reverse type 1 diabetes. Diabetes. 60: 693-4. PMID 21357468 DOI: 10.2337/Db10-1810 |
0.45 |
|
| 2011 |
Grimstein C, Choi YK, Wasserfall CH, Satoh M, Atkinson MA, Brantly ML, Campbell-Thompson M, Song S. Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model. Journal of Translational Medicine. 9: 21. PMID 21345239 DOI: 10.1186/1479-5876-9-21 |
0.36 |
|
| 2011 |
Lau K, Benitez P, Ardissone A, Wilson TD, Collins EL, Lorca G, Li N, Sankar D, Wasserfall C, Neu J, Atkinson MA, Shatz D, Triplett EW, Larkin J. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. Journal of Immunology (Baltimore, Md. : 1950). 186: 3538-46. PMID 21317395 DOI: 10.4049/Jimmunol.1001864 |
0.448 |
|
| 2011 |
Racine J, Wang M, Zhang C, Lin CL, Liu H, Todorov I, Atkinson M, Zeng D. Induction of mixed chimerism with MHC-mismatched but not matched bone marrow transplants results in thymic deletion of host-type autoreactive T-cells in NOD mice. Diabetes. 60: 555-64. PMID 21270266 DOI: 10.2337/Db10-0827 |
0.396 |
|
| 2011 |
Atkinson MA. It's time to consider changing the rules: the rationale for rethinking control groups in clinical trials aimed at reversing type 1 diabetes. Diabetes. 60: 361-3. PMID 21270247 DOI: 10.2337/Db10-1506 |
0.423 |
|
| 2011 |
El Haddad N, Heathcote D, Moore R, Yang S, Azzi J, Mfarrej B, Atkinson M, Sayegh MH, Lee JS, Ashton-Rickardt PG, Abdi R. Mesenchymal stem cells express serine protease inhibitor to evade the host immune response Blood. 117: 1176-1183. PMID 21076046 DOI: 10.1182/Blood-2010-06-287979 |
0.333 |
|
| 2011 |
Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, Drew JC, Ilonen J, Knip M, Hyöty H, Veijola R, Simell T, Simell O, Neu J, Wasserfall CH, ... Atkinson MA, et al. Toward defining the autoimmune microbiome for type 1 diabetes. The Isme Journal. 5: 82-91. PMID 20613793 DOI: 10.1038/Ismej.2010.92 |
0.45 |
|
| 2011 |
Rowe PA, Campbell-Thompson ML, Schatz DA, Atkinson MA. The pancreas in human type 1 diabetes. Seminars in Immunopathology. 33: 29-43. PMID 20495921 DOI: 10.1007/S00281-010-0208-X |
0.428 |
|
| 2011 |
Atkinson MA. Response to comment on: Atkinson. It's time to consider changing the rules: The rationale for rethinking control groups in clinical trials aimed at reversing type 1 diabetes. Diabetes 2011;60:361-363 Diabetes. 60. DOI: 10.2337/Db11-0365 |
0.445 |
|
| 2011 |
Giongo A, Atkinson MA, Triplett EW. Microbiology of Type 1 diabetes: possible implications for management of the disease Diabetes Management. 1: 325-331. DOI: 10.2217/Dmt.11.24 |
0.497 |
|
| 2011 |
Cabrera R, Ararat M, Cao M, Xu Y, Wasserfall C, Brusko T, Atkinson MA, Liu C, Nelson DR. Abstract 2702: Sorafenib modulates immune responses in patients with hepatocellular carcinoma Cancer Research. 71: 2702-2702. DOI: 10.1158/1538-7445.Am2011-2702 |
0.576 |
|
| 2010 |
Brophy S, Davies H, Stephens JW, Prior SL, Atkinson M, Bain S, Williams R. Adiponectin levels in people with Latent Autoimmune Diabetes-a case control study. Bmc Research Notes. 3: 317. PMID 21092154 DOI: 10.1186/1756-0500-3-317 |
0.311 |
|
| 2010 |
Cabrera R, Ararat M, Eksioglu EA, Cao M, Xu Y, Wasserfall C, Atkinson MA, Liu C, Nelson DR. Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma. Scandinavian Journal of Immunology. 72: 293-301. PMID 20883314 DOI: 10.1111/J.1365-3083.2010.02427.X |
0.306 |
|
| 2010 |
Jurewicz M, Yang S, Augello A, Godwin JG, Moore RF, Azzi J, Fiorina P, Atkinson M, Sayegh MH, Abdi R. Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes. 59: 3139-47. PMID 20841611 DOI: 10.2337/Db10-0542 |
0.459 |
|
| 2010 |
Vergani A, D'Addio F, Jurewicz M, Petrelli A, Watanabe T, Liu K, Law K, Schuetz C, Carvello M, Orsenigo E, Deng S, Rodig SJ, Ansari JM, Staudacher C, Abdi R, ... Atkinson M, et al. A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice. Diabetes. 59: 2253-64. PMID 20805386 DOI: 10.2337/Db09-1264 |
0.403 |
|
| 2010 |
Haller MJ, Atkinson MA, Schatz DA. Efforts to prevent and halt autoimmune beta cell destruction. Endocrinology and Metabolism Clinics of North America. 39: 527-39. PMID 20723818 DOI: 10.1016/J.Ecl.2010.05.006 |
0.363 |
|
| 2010 |
Schatz DA, Haller MJ, Atkinson MA. Type I diabetes. Preface. Endocrinology and Metabolism Clinics of North America. 39: xvii-xviii. PMID 20723814 DOI: 10.1016/J.Ecl.2010.05.012 |
0.482 |
|
| 2010 |
Li N, Hatch M, Wasserfall CH, Douglas-Escobar M, Atkinson MA, Schatz DA, Neu J. Butyrate and type 1 diabetes mellitus: can we fix the intestinal leak? Journal of Pediatric Gastroenterology and Nutrition. 51: 414-7. PMID 20706153 DOI: 10.1097/Mpg.0B013E3181Dd913A |
0.478 |
|
| 2010 |
Brusko TM, Koya RC, Zhu S, Lee MR, Putnam AL, McClymont SA, Nishimura MI, Han S, Chang LJ, Atkinson MA, Ribas A, Bluestone JA. Human antigen-specific regulatory T cells generated by T cell receptor gene transfer. Plos One. 5: e11726. PMID 20668510 DOI: 10.1371/Journal.Pone.0011726 |
0.681 |
|
| 2010 |
Tao B, Pietropaolo M, Atkinson M, Schatz D, Taylor D. Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method Plos One. 5. PMID 20634976 DOI: 10.1371/Journal.Pone.0011501 |
0.44 |
|
| 2010 |
Ma H, Lu Y, Li H, Campbell-Thompson M, Parker M, Wasserfall C, Haller M, Brantly M, Schatz D, Atkinson M, Song S. Intradermal alpha1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease. Diabetologia. 53: 2198-204. PMID 20593162 DOI: 10.1007/S00125-010-1829-2 |
0.481 |
|
| 2010 |
Nierras CR, Atkinson MA, Goldstein RA. The juvenile diabetes research foundation at forty: Updates of research in type 1 diabetes Diabetes. 59: 1575-1577. PMID 20587801 DOI: 10.2337/Db10-0622 |
0.456 |
|
| 2010 |
Zhang C, Wang M, Racine JJ, Liu H, Lin CL, Nair I, Lau J, Cao YA, Todorov I, Atkinson M, Zeng D. Induction of chimerism permits low-dose islet grafts in the liver or pancreas to reverse refractory autoimmune diabetes. Diabetes. 59: 2228-36. PMID 20530743 DOI: 10.2337/Db10-0450 |
0.467 |
|
| 2010 |
Shoda L, Kreuwel H, Gadkar K, Zheng Y, Whiting C, Atkinson M, Bluestone J, Mathis D, Young D, Ramanujan S. The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse. Clinical and Experimental Immunology. 161: 250-67. PMID 20491795 DOI: 10.1111/J.1365-2249.2010.04166.X |
0.654 |
|
| 2010 |
Valladares R, Sankar D, Li N, Williams E, Lai KK, Abdelgeliel AS, Gonzalez CF, Wasserfall CH, Larkin J, Schatz D, Atkinson MA, Triplett EW, Neu J, Lorca GL. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. Plos One. 5: e10507. PMID 20463897 DOI: 10.1371/Journal.Pone.0010507 |
0.463 |
|
| 2010 |
Gianani R, Campbell-Thompson M, Sarkar SA, Wasserfall C, Pugliese A, Solis JM, Kent SC, Hering BJ, West E, Steck A, Bonner-Weir S, Atkinson MA, Coppieters K, von Herrath M, Eisenbarth GS. Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia. 53: 690-8. PMID 20062967 DOI: 10.1007/S00125-009-1642-Y |
0.492 |
|
| 2010 |
Gagliani N, Jofra T, Stabilini A, Valle A, Atkinson M, Roncarolo MG, Battaglia M. Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant. Diabetes. 59: 433-439. PMID 19934002 DOI: 10.2337/Db09-1168 |
0.383 |
|
| 2010 |
Xue S, Wasserfall C, Parker M, McGrail S, McGrail K, Campbell-Thompson M, Schatz DA, Atkinson MA, Haller MJ. Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area. Journal of Diabetes and Its Complications. 24: 163-7. PMID 19217320 DOI: 10.1016/J.Jdiacomp.2008.12.004 |
0.504 |
|
| 2010 |
Gianani R, Campbell-Thompson M, Sarkar SA, Wasserfall C, Pugliese A, Solis JM, Kent SC, Hering BJ, West E, Steck A, Bonner-Weir S, Atkinson MA, Coppieters K, von Herrath M, Eisenbarth GS. Erratum to: Dimorphic histopathology of long-standing childhood-onset diabetes Diabetologia. 53: 1811-1812. DOI: 10.1007/S00125-010-1769-X |
0.341 |
|
| 2009 |
Brusko TM, Wasserfall CH, Hulme MA, Cabrera R, Schatz D, Atkinson MA. Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation. Plos One. 4: e7980. PMID 19956753 DOI: 10.1371/Journal.Pone.0007980 |
0.6 |
|
| 2009 |
Haller MJ, Wasserfall CH, McGrail KM, Cintron M, Brusko TM, Wingard JR, Kelly SS, Shuster JJ, Atkinson MA, Schatz DA. Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care. 32: 2041-6. PMID 19875605 DOI: 10.2337/Dc09-0967 |
0.626 |
|
| 2009 |
Bierschenk L, Alexander J, Wasserfall C, Haller M, Schatz D, Atkinson M. Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care. 32: 1977-9. PMID 19675194 DOI: 10.2337/Dc09-1089 |
0.406 |
|
| 2009 |
Haller MJ, Atkinson MA, Schatz DA. The road not taken: a path to curing type 1 diabetes? European Journal of Immunology. 39: 2054-8. PMID 19672902 DOI: 10.1002/Eji.200939517 |
0.473 |
|
| 2009 |
Yip L, Su L, Sheng D, Chang P, Atkinson M, Czesak M, Albert PR, Collier AR, Turley SJ, Fathman CG, Creusot RJ. Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes. Nature Immunology. 10: 1026-33. PMID 19668219 DOI: 10.1038/Ni.1773 |
0.44 |
|
| 2009 |
Parker MJ, Xue S, Alexander JJ, Wasserfall CH, Campbell-Thompson ML, Battaglia M, Gregori S, Mathews CE, Song S, Troutt M, Eisenbeis S, Williams J, Schatz DA, Haller MJ, Atkinson MA. Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice. Diabetes. 58: 2277-84. PMID 19628781 DOI: 10.2337/Db09-0557 |
0.51 |
|
| 2009 |
Nayak S, Cao O, Hoffman BE, Cooper M, Zhou S, Atkinson MA, Herzog RW. Prophylactic immune tolerance induced by changing the ratio of antigen-specific effector to regulatory T cells Journal of Thrombosis and Haemostasis. 7: 1523-1532. PMID 19583824 DOI: 10.1111/J.1538-7836.2009.03548.X |
0.381 |
|
| 2009 |
Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, La Rosa S, Selig M, Godwin J, Law K, Placidi C, Smith RN, Capella C, Rodig S, Adra CN, Atkinson M, et al. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. Journal of Immunology (Baltimore, Md. : 1950). 183: 993-1004. PMID 19561093 DOI: 10.4049/Jimmunol.0900803 |
0.375 |
|
| 2009 |
Atkinson MA, Gianani R. The pancreas in human type 1 diabetes: providing new answers to age-old questions. Current Opinion in Endocrinology, Diabetes, and Obesity. 16: 279-85. PMID 19502978 DOI: 10.1097/Med.0B013E32832E06Ba |
0.472 |
|
| 2009 |
Araya C, Diaz L, Wasserfall C, Atkinson M, Mu W, Johnson R, Garin E. T regulatory cell function in idiopathic minimal lesion nephrotic syndrome. Pediatric Nephrology (Berlin, Germany). 24: 1691-8. PMID 19495805 DOI: 10.1007/S00467-009-1214-X |
0.335 |
|
| 2009 |
Huang Y, Parker M, Xia C, Peng R, Wasserfall C, Clarke T, Wu L, Chowdhry T, Campbell-Thompson M, Williams J, Clare-Salzler M, Atkinson MA, Womer KL. Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses. Journal of Immunology (Baltimore, Md. : 1950). 182: 4608-15. PMID 19342635 DOI: 10.4049/Jimmunol.0713269 |
0.463 |
|
| 2009 |
Kosugi T, Heinig M, Nakayama T, Connor T, Yuzawa Y, Li Q, Hauswirth WW, Grant MB, Croker BP, Campbell-Thompson M, Zhang L, Atkinson MA, Segal MS, Nakagawa T. Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice. The American Journal of Pathology. 174: 1221-9. PMID 19246639 DOI: 10.2353/Ajpath.2009.080605 |
0.381 |
|
| 2009 |
Roesch LF, Lorca GL, Casella G, Giongo A, Naranjo A, Pionzio AM, Li N, Mai V, Wasserfall CH, Schatz D, Atkinson MA, Neu J, Triplett EW. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. The Isme Journal. 3: 536-48. PMID 19225551 DOI: 10.1038/Ismej.2009.5 |
0.432 |
|
| 2009 |
Valle A, Jofra T, Stabilini A, Atkinson M, Roncarolo MG, Battaglia M. Rapamycin Prevents and Breaks the Anti-CD3–Induced Tolerance in NOD Mice Diabetes. 58: 875-881. PMID 19151201 DOI: 10.2337/Db08-1432 |
0.46 |
|
| 2009 |
Wasserfall C, Atkinson MA. Taking a daily vitamin to prevent type 1 diabetes? Diabetes. 58: 24-5. PMID 19114727 DOI: 10.2337/Db08-1479 |
0.471 |
|
| 2009 |
Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes. 58: 652-62. PMID 19074986 DOI: 10.2337/Db08-1168 |
0.716 |
|
| 2009 |
Campbell-Thompson M, Dixon LR, Wasserfall C, Monroe M, McGuigan JM, Schatz D, Crawford JM, Atkinson MA. Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area. Diabetologia. 52: 262-70. PMID 19002428 DOI: 10.1007/S00125-008-1200-Z |
0.36 |
|
| 2009 |
Parker M, Xue S, Wasserfall C, Campbell-Thompson M, Atkinson M. T.8. Amelioration of Insulitis and Reversal of Diabetes in NOD Mice by Murine Anti-Thymocyte Globulin and Granulocyte-Colony Stimulating Factor Combination Therapy Clinical Immunology. 131. DOI: 10.1016/J.Clim.2009.03.137 |
0.427 |
|
| 2008 |
Xue S, Wasserfall CH, Parker M, Brusko TM, McGrail S, McGrail K, Moore M, Campbell-Thompson M, Schatz DA, Atkinson MA, Haller MJ. Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency. Annals of the New York Academy of Sciences. 1150: 152-6. PMID 19120286 DOI: 10.1196/Annals.1447.049 |
0.664 |
|
| 2008 |
Sanjeevi CB, Schatz DA, Atkinson MA. The IDS conducts standardization of assays for the measurement of autoantibodies and of T cells in autoimmune diabetes. Preface. Annals of the New York Academy of Sciences. 1150: xiii. PMID 19120260 DOI: 10.1196/Annals.1447.066 |
0.471 |
|
| 2008 |
Suarez-Pinzon WL, Power RF, Yan Y, Wasserfall C, Atkinson M, Rabinovitch A. Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD Mice Diabetes. 57: 3281-3288. PMID 18835930 DOI: 10.2337/Db08-0688 |
0.453 |
|
| 2008 |
Vaarala O, Atkinson MA, Neu J. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 57: 2555-62. PMID 18820210 DOI: 10.2337/Db08-0331 |
0.478 |
|
| 2008 |
Stalvey MS, Brusko TM, Mueller C, Wasserfall CH, Schatz DA, Atkinson MA, Flotte TR. CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes. Cytokine. 44: 154-9. PMID 18778952 DOI: 10.1016/J.Cyto.2008.07.468 |
0.601 |
|
| 2008 |
Lu Y, Parker M, Pileggi A, Zhang B, Choi Y-, Molano RD, Wasserfall C, Ricordi C, Inverardi L, Brantly M, Schatz D, Atkinson M, Song S. Human alpha 1‐antitrypsin therapy induces fatal anaphylaxis in non‐obese diabetic mice Clinical and Experimental Immunology. 154: 15-21. PMID 18759852 DOI: 10.1111/J.1365-2249.2008.03721.X |
0.376 |
|
| 2008 |
Sato W, Kosugi T, Zhang L, Roncal CA, Heinig M, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Grant MB, Croker BP, Nakagawa T. The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 949-61. PMID 18607348 DOI: 10.1038/Labinvest.2008.60 |
0.422 |
|
| 2008 |
Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH. Immunomodulation by Mesenchymal Stem Cells A Potential Therapeutic Strategy for Type 1 Diabetes Diabetes. 57: 1759-1767. PMID 18586907 DOI: 10.2337/Db08-0180 |
0.383 |
|
| 2008 |
George JF, Braun A, Brusko TM, Joseph R, Bolisetty S, Wasserfall CH, Atkinson MA, Agarwal A, Kapturczak MH. Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. The American Journal of Pathology. 173: 154-60. PMID 18511516 DOI: 10.2353/Ajpath.2008.070963 |
0.617 |
|
| 2008 |
Haller MJ, Viener HL, Wasserfall C, Brusko T, Atkinson MA, Schatz DA. Autologous umbilical cord blood infusion for type 1 diabetes. Experimental Hematology. 36: 710-5. PMID 18358588 DOI: 10.1016/J.Exphem.2008.01.009 |
0.646 |
|
| 2008 |
King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clinical Immunology (Orlando, Fla.). 126: 303-14. PMID 18096436 DOI: 10.1016/J.Clim.2007.11.001 |
0.324 |
|
| 2008 |
Caicedo RA, Li N, Des Robert C, Scumpia PO, Hubsher CP, Wasserfall CH, Schatz DA, Atkinson MA, Neu J. Neonatal formula feeding leads to immunological alterations in an animal model of type 1 diabetes. Pediatric Research. 63: 303-7. PMID 18091354 DOI: 10.1203/Pdr.0B013E31815Ed662 |
0.402 |
|
| 2008 |
Koya V, Lu S, Sun YP, Purich DL, Atkinson MA, Li SW, Yang LJ. Reversal of streptozotocin-induced diabetes in mice by cellular transduction with recombinant pancreatic transcription factor pancreatic duodenal homeobox-1: a novel protein transduction domain-based therapy. Diabetes. 57: 757-69. PMID 18086901 DOI: 10.2337/Db07-1441 |
0.449 |
|
| 2008 |
Simon G, Parker M, Ramiya V, Wasserfall C, Huang Y, Bresson D, Schwartz RF, Campbell-Thompson M, Tenace L, Brusko T, Xue S, Scaria A, Lukason M, Eisenbeis S, Williams J, ... Atkinson MA, et al. Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation. Diabetes. 57: 405-14. PMID 18039815 DOI: 10.2337/Db06-1384 |
0.651 |
|
| 2008 |
Nayak S, Hoffman B, Cooper M, Atkinson M, Cao O, Herzog RW. A Prophylactic Protocol for the Prevention of Inhibitor Formation in Gene Therapy for Hemophilia B by Shifting the Balance from An Effector to a Regulatory T Cell Response Blood. 112: 3531-3531. DOI: 10.1182/Blood.V112.11.3531.3531 |
0.382 |
|
| 2008 |
Pileggi A, Molano RD, Jose SS, Zahr E, Molina J, An W, Gonzalez-Quintana J, Atkinson MA, Ricordi C, Inverardi L. Targeted Bone Marrow Radioablation Enhances Hematopoietic Chimerism And Prevention Diabetes Onset In Nod Mice.: 2235 Transplantation. 86: 731. DOI: 10.1097/01.Tp.0000330583.35887.5F |
0.386 |
|
| 2007 |
Brusko TM, Hulme MA, Myhr CB, Haller MJ, Atkinson MA. Assessing the in vitro suppressive capacity of regulatory T cells. Immunological Investigations. 36: 607-28. PMID 18161521 DOI: 10.1080/08820130701790368 |
0.596 |
|
| 2007 |
Brusko T, Atkinson M. Treg in type 1 diabetes. Cell Biochemistry and Biophysics. 48: 165-75. PMID 17709886 DOI: 10.1007/S12013-007-0018-5 |
0.709 |
|
| 2007 |
Scumpia PO, Delano MJ, Kelly-Scumpia KM, Weinstein JS, Wynn JL, Winfield RD, Xia C, Chung CS, Ayala A, Atkinson MA, Reeves WH, Clare-Salzler MJ, Moldawer LL. Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood. 110: 3673-81. PMID 17690255 DOI: 10.1182/Blood-2007-04-087171 |
0.373 |
|
| 2007 |
Lowe CE, Cooper JD, Brusko T, Walker NM, Smyth DJ, Bailey R, Bourget K, Plagnol V, Field S, Atkinson M, Clayton DG, Wicker LS, Todd JA. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nature Genetics. 39: 1074-82. PMID 17676041 DOI: 10.1038/Ng2102 |
0.613 |
|
| 2007 |
Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB, Rugeles MT, Atkinson MA, Landay AL, Wilson SB. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology. 122: 1-14. PMID 17662044 DOI: 10.1111/J.1365-2567.2007.02647.X |
0.407 |
|
| 2007 |
Guleria I, Gubbels Bupp M, Dada S, Fife B, Tang Q, Ansari MJ, Trikudanathan S, Vadivel N, Fiorina P, Yagita H, Azuma M, Atkinson M, Bluestone JA, Sayegh MH. Mechanisms of PDL1-mediated regulation of autoimmune diabetes. Clinical Immunology (Orlando, Fla.). 125: 16-25. PMID 17627890 DOI: 10.1016/J.Clim.2007.05.013 |
0.602 |
|
| 2007 |
Zheng Y, Kreuwel HT, Young DL, Shoda LK, Ramanujan S, Gadkar KG, Atkinson MA, Whiting CC. The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetes. Annals of the New York Academy of Sciences. 1103: 45-62. PMID 17376834 DOI: 10.1196/Annals.1394.014 |
0.531 |
|
| 2007 |
King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson M, Wasserfall C, Herold K, Mordes JP, Rossini AA, Greiner DL. Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity Annals of the New York Academy of Sciences. 1103: 90-93. PMID 17376822 DOI: 10.1196/Annals.1394.011 |
0.315 |
|
| 2007 |
Zhang B, Lu Y, Campbell-Thompson M, Spencer T, Wasserfall C, Atkinson M, Song S. Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes. 56: 1316-23. PMID 17360983 DOI: 10.2337/Db06-1273 |
0.418 |
|
| 2007 |
Brusko T, Wasserfall C, McGrail K, Schatz R, Viener HL, Schatz D, Haller M, Rockell J, Gottlieb P, Clare-Salzler M, Atkinson M. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes. 56: 604-12. PMID 17327427 DOI: 10.2337/Db06-1248 |
0.63 |
|
| 2007 |
Zhang C, Todorov I, Lin CL, Atkinson M, Kandeel F, Forman S, Zeng D. Elimination of insulitis and augmentation of islet beta cell regeneration via induction of chimerism in overtly diabetic NOD mice. Proceedings of the National Academy of Sciences of the United States of America. 104: 2337-42. PMID 17267595 DOI: 10.1073/Pnas.0611101104 |
0.519 |
|
| 2007 |
Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. Journal of the American Society of Nephrology : Jasn. 18: 539-50. PMID 17202420 DOI: 10.1681/Asn.2006050459 |
0.435 |
|
| 2007 |
Schwartz RF, Neu J, Schatz D, Atkinson MA, Wasserfall C. Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105-2108 [4] Diabetologia. 50: 220-221. PMID 17119915 DOI: 10.1007/S00125-006-0526-7 |
0.455 |
|
| 2007 |
Zhang C, Kandeel F, Todorov I, Atkinson M, Lin C, Forman S, Zeng D. Elimination of Insulitis and Augmentation of Islet β Cell Regeneration via Induction of Chimerism in Overtly Diabetic NOD Mice Clinical Immunology. 123. DOI: 10.1016/J.Clim.2007.03.474 |
0.455 |
|
| 2007 |
Brusko T, Wasserfall C, McGrail K, Moore M, Huegel A, Schatz D, Atkinson M. Regulatory T Cells Require Serum for Suppression of Effector T Cell Proliferation and Express Stable Membrane-bound CD25 Clinical Immunology. 123: S4. DOI: 10.1016/J.Clim.2007.03.183 |
0.591 |
|
| 2006 |
Scumpia PO, Delano MJ, Kelly KM, O'Malley KA, Efron PA, McAuliffe PF, Brusko T, Ungaro R, Barker T, Wynn JL, Atkinson MA, Reeves WH, Salzler MJ, Moldawer LL. Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. Journal of Immunology (Baltimore, Md. : 1950). 177: 7943-9. PMID 17114466 DOI: 10.4049/Jimmunol.177.11.7943 |
0.605 |
|
| 2006 |
Blenman KR, Duan B, Xu Z, Wan S, Atkinson MA, Flotte TR, Croker BP, Morel L. IL-10 regulation of lupus in the NZM2410 murine model. Laboratory Investigation; a Journal of Technical Methods and Pathology. 86: 1136-48. PMID 16924244 DOI: 10.1038/Labinvest.3700468 |
0.313 |
|
| 2006 |
Wasserfall CH, Atkinson MA. Autoantibody markers for the diagnosis and prediction of type 1 diabetes Autoimmunity Reviews. 5: 424-428. PMID 16890898 DOI: 10.1016/J.Autrev.2005.12.002 |
0.519 |
|
| 2006 |
Stalvey MS, Muller C, Schatz DA, Wasserfall CH, Campbell-Thompson ML, Theriaque DW, Flotte TR, Atkinson MA. Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury. Diabetes. 55: 1939-45. PMID 16804061 DOI: 10.2337/Db05-1647 |
0.341 |
|
| 2006 |
Lu Y, Tang M, Wasserfall C, Kou Z, Campbell-Thompson M, Gardemann T, Crawford J, Atkinson M, Song S. Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice. Human Gene Therapy. 17: 625-34. PMID 16776571 DOI: 10.1089/Hum.2006.17.625 |
0.508 |
|
| 2006 |
Tang DQ, Cao LZ, Chou W, Shun L, Farag C, Atkinson MA, Li SW, Chang LJ, Yang LJ. Role of Pax4 in Pdx1-VP16-mediated liver-to-endocrine pancreas transdifferentiation. Laboratory Investigation; a Journal of Technical Methods and Pathology. 86: 829-41. PMID 16732298 DOI: 10.1038/Labinvest.3700434 |
0.346 |
|
| 2006 |
Chen S, Wasserfall C, Kapturczak MH, Atkinson M, Agarwal A. Freeze-thaw increases adeno-associated virus transduction of cells. American Journal of Physiology. Cell Physiology. 291: C386-92. PMID 16510845 DOI: 10.1152/Ajpcell.00582.2005 |
0.315 |
|
| 2006 |
Nakagawa T, Sato W, Sautin YY, Glushakova O, Croker B, Atkinson MA, Tisher CC, Johnson RJ. Uncoupling of Vascular Endothelial Growth Factor with Nitric Oxide as a Mechanism for Diabetic Vasculopathy Journal of the American Society of Nephrology. 17: 736-745. PMID 16436494 DOI: 10.1681/Asn.2005070759 |
0.318 |
|
| 2006 |
Müller C, Braag SA, Herlihy JD, Wasserfall CH, Chesrown SE, Nick HS, Atkinson MA, Flotte TR. Enhanced IgE allergic response to Aspergillus fumigatus in CFTR-/- mice. Laboratory Investigation; a Journal of Technical Methods and Pathology. 86: 130-40. PMID 16424881 DOI: 10.1038/Labinvest.3700379 |
0.309 |
|
| 2006 |
Burkhardt BR, Greene SR, White P, Wong RK, Brestelli JE, Yang J, Robert CE, Brusko TM, Wasserfall CH, Wu J, Atkinson MA, Gao Z, Kaestner KH, Wolf BA. PANDER-induced cell-death genetic networks in islets reveal central role for caspase-3 and cyclin-dependent kinase inhibitor 1A (p21). Gene. 369: 134-41. PMID 16412588 DOI: 10.1016/J.Gene.2005.10.040 |
0.57 |
|
| 2006 |
Burkhardt BR, Lyle R, Qian K, Arnold AS, Cheng H, Atkinson MA, Zhang YC. Efficient delivery of siRNA into cytokine-stimulated insulinoma cells silences Fas expression and inhibits Fas-mediated apoptosis. Febs Letters. 580: 553-60. PMID 16412430 DOI: 10.1016/J.Febslet.2005.12.068 |
0.368 |
|
| 2006 |
Lee CH, Chen YG, Chen J, Reifsnyder PC, Serreze DV, Clare-Salzler M, Rodriguez M, Wasserfall C, Atkinson MA, Leiter EH. Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: II. Immunologic analysis. Diabetes. 55: 171-8. PMID 16380490 |
0.423 |
|
| 2006 |
Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TWH, Lee-Chan E, Singh B. International Workshop on Lessons from Animal Models for Human Type 1 Diabetes Annals of the New York Academy of Sciences. 958: 1-2. PMID 12021078 DOI: 10.1111/J.1749-6632.2002.Tb02941.X |
0.46 |
|
| 2006 |
Song S, Lu Y, Tang M, Zhang B, Wasserfall C, Campbell-Thompson M, Atkinson M. 71. Alpha 1 Antitrypsin (AAT) Gene Therapy for the Prevention of Type 1 Diabetes Molecular Therapy. 13. DOI: 10.1016/J.Ymthe.2006.08.088 |
0.508 |
|
| 2006 |
Guleria I, Dada S, Eckenrode S, Bupp MG, Ansari M, Vadivel N, Trikudanathan S, Fiorina P, Khosroshahi A, Yagita H, Azuma M, Atkinson M, She J, Bluestone J, Sayegh M. Su.26. PDL1 Regulates Autoimmunity By Limiting Expansion of Autoreactive Th1 Cells and Mediates Resistance to Diabetes in Nod Mice Clinical Immunology. 119: S168. DOI: 10.1016/J.Clim.2006.04.453 |
0.601 |
|
| 2005 |
Fudge E, Carol J, She JX, Dosch M, Atkinson M, Muir A. Chronic inflammatory demyelinating polyradiculoneuropathy in two children with type 1 diabetes mellitus. Pediatric Diabetes. 6: 244-248. PMID 16390395 DOI: 10.1111/J.1399-543X.2005.00130.X |
0.48 |
|
| 2005 |
Haller MJ, Atkinson MA, Schatz D. Type 1 diabetes mellitus: Etiology, presentation, and management Pediatric Clinics of North America. 52: 1553-1578. PMID 16301083 DOI: 10.1016/J.Pcl.2005.07.006 |
0.47 |
|
| 2005 |
Burkhardt BR, Parker MJ, Zhang YC, Song S, Wasserfall CH, Atkinson MA. Glucose transporter-2 (GLUT2) promoter mediated transgenic insulin production reduces hyperglycemia in diabetic mice. Febs Letters. 579: 5759-64. PMID 16223491 DOI: 10.1016/J.Febslet.2005.09.060 |
0.388 |
|
| 2005 |
Atkinson MA, Rhodes CJ. Pancreatic regeneration in type 1 diabetes: Dreams on a deserted islet? Diabetologia. 48: 2200-2202. PMID 16193285 DOI: 10.1007/S00125-005-1957-2 |
0.478 |
|
| 2005 |
Litherland SA, Grebe KM, Belkin NS, Paek E, Elf J, Atkinson M, Morel L, Clare-Salzler MJ, McDuffie M. Nonobese diabetic mouse congenic analysis reveals chromosome 11 locus contributing to diabetes susceptibility, macrophage STAT5 dysfunction, and granulocyte-macrophage colony-stimulating factor overproduction. Journal of Immunology (Baltimore, Md. : 1950). 175: 4561-5. PMID 16177100 DOI: 10.4049/Jimmunol.175.7.4561 |
0.417 |
|
| 2005 |
Zhang YC, Pileggi A, Molano RD, Wasserfall C, Campbell-Thompson M, Ricordi C, Atkinson MA, Inverardi L. Systemic overexpression of interleukin-10 fails to protect allogeneic islet transplants in nonobese diabetic mice. Transplantation. 80: 530-533. PMID 16123729 DOI: 10.1097/01.Tp.0000168212.53172.06 |
0.38 |
|
| 2005 |
Lee CH, Reifsnyder PC, Naggert JK, Wasserfall C, Atkinson MA, Chen J, Leiter EH. Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: I. Pathophysiological analysis Diabetes. 54: 2525-2532. PMID 16123339 DOI: 10.2337/Diabetes.54.9.2525 |
0.444 |
|
| 2005 |
Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, Bluestone JA, Eisenbarth GS, Mathis D, Rossini AA, Campbell SE, Kahn R, Kreuwel HT. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity. 23: 115-26. PMID 16111631 DOI: 10.1016/J.Immuni.2005.08.002 |
0.573 |
|
| 2005 |
Loiler SA, Tang Q, Clarke T, Campbell-Thompson ML, Chiodo V, Hauswirth W, Cruz P, Perret-Gentil M, Atkinson MA, Ramiya VK, Flotte TR. Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 519-27. PMID 15979413 DOI: 10.1016/J.Ymthe.2005.04.017 |
0.357 |
|
| 2005 |
Neu J, Reverte CM, Mackey AD, Liboni K, Tuhacek-Tenace LM, Hatch M, Li N, Caicedo RA, Schatz DA, Atkinson M. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. Journal of Pediatric Gastroenterology and Nutrition. 40: 589-95. PMID 15861021 DOI: 10.1097/01.Mpg.0000159636.19346.C1 |
0.471 |
|
| 2005 |
Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA. Functional defects and the influence of age on the frequency of CD4 +CD25+ T-cells in type 1 diabetes Diabetes. 54: 1407-1414. PMID 15855327 DOI: 10.2337/Diabetes.54.5.1407 |
0.678 |
|
| 2005 |
Atkinson MA. Thirty years of investigating the autoimmune basis for type 1 diabetes: Why can't we prevent or reverse this disease? Diabetes. 54: 1253-1263. PMID 15855308 DOI: 10.2337/Diabetes.54.5.1253 |
0.503 |
|
| 2005 |
Brusko TM, Wasserfall CH, Agarwal A, Kapturczak MH, Atkinson MA. An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 174: 5181-6. PMID 15843512 DOI: 10.4049/Jimmunol.174.9.5181 |
0.602 |
|
| 2005 |
Li M, Guo D, Isales CM, Eizirik DL, Atkinson M, She JX, Wang CY. SUMO wrestling with type 1 diabetes. Journal of Molecular Medicine (Berlin, Germany). 83: 504-13. PMID 15806321 DOI: 10.1007/S00109-005-0645-5 |
0.392 |
|
| 2005 |
Ramirez-Montealegre D, Chattopadhyay S, Curran TM, Wasserfall C, Pritchard L, Schatz D, Petitto J, Hopkins D, She JX, Rothberg PG, Atkinson M, Pearce DA. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Neurology. 64: 743-5. PMID 15728308 DOI: 10.1212/01.Wnl.0000151973.08426.7E |
0.401 |
|
| 2005 |
Serreze DV, Wasserfall C, Ottendorfer EW, Stalvey M, Pierce MA, Gauntt C, O'Donnell B, Flanagan JB, Campbell-Thompson M, Ellis TM, Atkinson MA. Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon. Journal of Virology. 79: 1045-52. PMID 15613333 DOI: 10.1128/Jvi.79.2.1045-1052.2005 |
0.415 |
|
| 2005 |
Greenbaum CJ, Eisenbarth G, Atkinson M, Yu L, Babu S, Schatz D, Zeidler A, Orban T, Wasserfall C, Cuthbertson D, Krischer J. High frequency of abnormal glucose tolerance in DQA1*0102/ DQB1*0602 relatives identified as part of the Diabetes Prevention Trial - Type 1 Diabetes Diabetologia. 48: 68-74. PMID 15602651 DOI: 10.1007/S00125-004-1608-Z |
0.483 |
|
| 2005 |
Liang Y, Huang T, Zhang C, Todorov I, Atkinson M, Kandeel F, Forman S, Zeng D. Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb. Blood. 105: 2180-8. PMID 15374883 DOI: 10.1182/Blood-2004-06-2411 |
0.391 |
|
| 2005 |
Morales A, Wasserfall C, Brusko T, Carter C, Schatz D, Silverstein J, Ellis T, Atkinson M. Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care. 27: 2010-4. PMID 15277432 DOI: 10.2337/Diacare.27.8.2010 |
0.678 |
|
| 2005 |
Lee C, Chen Y, Chen J, Reifsnyder PC, Serreze DV, Clare-Salzler M, Rodriguez M, Wasserfall C, Atkinson MA, Leiter EH. Novel Leptin Receptor Mutation in NOD/LtJ Mice Suppresses Type 1 Diabetes Progression: II. Immunologic Analysis Diabetes. 55: 171-178. DOI: 10.2337/Diabetes.55.01.06.Db05-1129 |
0.51 |
|
| 2005 |
Caicedo RA, Li N, Atkinson MA, Schatz DA, Neu J. Neonatal Nutritional Interventions in the Prevention of Type 1 Diabetes Neoreviews. 6: e220-e226. DOI: 10.1542/Neo.6-5-E220 |
0.486 |
|
| 2005 |
Muller C, Braag SA, Martino A, Atkinson MA, Flotte TR. 1083. Systemic rAAV-CB-IL-10 Expression and Its Long Term Effects on CD4+CD25+ T Cell Populations Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.630 |
0.354 |
|
| 2005 |
Simon GG, Schwartz F, Wasserfall C, Atkinson MA. 914. A Dichotomous Role for Interleukin-10 in the Pathogenesis of Type 1 Diabetes Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.457 |
0.364 |
|
| 2004 |
Roep BO, Atkinson M, Herrath Mv. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes Nature Reviews Immunology. 4: 989-997. PMID 15573133 DOI: 10.1038/Nri1502 |
0.464 |
|
| 2004 |
Haller MJ, Samyn M, Nichols WW, Brusko T, Wasserfall C, Schwartz RF, Atkinson M, Shuster JJ, Pierce GL, Silverstein JH. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes Diabetes Care. 27: 2911-2917. PMID 15562206 DOI: 10.2337/Diacare.27.12.2911 |
0.631 |
|
| 2004 |
You S, Chen C, Lee WH, Brusko T, Atkinson M, Liu CP. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice. Journal of Immunology (Baltimore, Md. : 1950). 173: 6777-85. PMID 15557171 DOI: 10.4049/Jimmunol.173.11.6777 |
0.657 |
|
| 2004 |
Roep BO, Atkinson M. Animal models have little to teach us about Type 1 diabetes: 1. In support of this proposal Diabetologia. 47: 1650-1656. PMID 15490110 DOI: 10.1007/S00125-004-1517-1 |
0.51 |
|
| 2004 |
Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. The American Journal of Pathology. 165: 1045-53. PMID 15331427 DOI: 10.1016/S0002-9440(10)63365-2 |
0.583 |
|
| 2004 |
Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S, Podolsky RH, Muir A, Wang J, Dong Z, Brusko T, Atkinson M, Pozzilli P, et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nature Genetics. 36: 837-41. PMID 15247916 DOI: 10.1038/Ng1391 |
0.605 |
|
| 2004 |
Tang DQ, Cao LZ, Burkhardt BR, Xia CQ, Litherland SA, Atkinson MA, Yang LJ. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow Diabetes. 53: 1721-1732. PMID 15220196 DOI: 10.2337/Diabetes.53.7.1721 |
0.388 |
|
| 2004 |
Schatz D, Cuthbertson D, Atkinson M, Salzler MC, Winter W, Muir A, Silverstein J, Cook R, Maclaren N, She J, Greenbaum C, Krischer J. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression? Pediatric Diabetes. 5: 72-79. PMID 15189492 DOI: 10.1111/J.1399-543X.2004.00047.X |
0.456 |
|
| 2004 |
Gale EAM, Atkinson M. A piece of nucleic acid surrounded by controversy: coxsackievirus and the causes of Type 1 diabetes. Diabetic Medicine. 21: 503-506. PMID 15154931 DOI: 10.1111/J.1464-5491.2004.01181.X |
0.442 |
|
| 2004 |
Lu Y, Dang H, Middleton B, Zhang Z, Washburn L, Campbell-Thompson M, Atkinson MA, Gambhir SS, Tian J, Kaufman DL. Bioluminescent monitoring of islet graft survival after transplantation. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 428-35. PMID 15006610 DOI: 10.1016/J.Ymthe.2004.01.008 |
0.305 |
|
| 2004 |
Zhang YC, Powers M, Wasserfall C, Brusko T, Song S, Flotte T, Snyder RO, Potter M, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Nick HS, Agarwal A, Ellis TM, Atkinson MA. Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity. Gene Therapy. 11: 233-40. PMID 14737082 DOI: 10.1038/Sj.Gt.3302144 |
0.577 |
|
| 2004 |
Song S, Goudy K, Campbell-Thompson M, Wasserfall C, Scott-Jorgensen M, Wang J, Tang Q, Crawford JM, Ellis TM, Atkinson MA, Flotte TR. Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice Gene Therapy. 11: 181-186. PMID 14712302 DOI: 10.1038/Sj.Gt.3302156 |
0.487 |
|
| 2004 |
Yu L, Eisenbarth G, Bonifacio E, Thomas J, Atkinson M, Wasserfall C. The second murine autoantibody workshop: remarkable interlaboratory concordance for radiobinding assays to identify insulin autoantibodies in nonobese diabetic mice. Annals of the New York Academy of Sciences. 1005: 1-12. PMID 14679035 DOI: 10.1196/Annals.1288.002 |
0.444 |
|
| 2004 |
Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S, Podolsky RH, Muir A, Wang J, Dong Z, Brusko T, Atkinson M, Pozzilli P, et al. Erratum: Corrigendum: A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes Nature Genetics. 36: 1024-1024. DOI: 10.1038/Ng0904-1024B |
0.611 |
|
| 2004 |
Lu Y, Tang M, Wasserfall C, Choi Y, Gardmann T, Campbell-Thompson M, Atkinson MA, Song S. 429. Alpha 1 Antitrypsin Gene Delivery for Preventing Type 1 Diabetes in NOD Mice|[ast]| Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.384 |
0.473 |
|
| 2004 |
Cresawn KO, Wasserfall C, Atkinson MA, Mah C, Fraites TJ, Zolotukhin I, Byrne BJ. 250. Cross-Correction in Pompe Mice after Immunomodulation and Hepatic Delivery of Recombinant AAA5 and AAV8 Vectors Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.191 |
0.307 |
|
| 2004 |
Loiler SA, Tang Q, Perret-Gentil M, Campbell-Thompson ML, Atkinson MA, Flotte TR. 169. Intrapancreatic injections of adeno-associated virus vectors for local gene expression Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.129 |
0.418 |
|
| 2003 |
Burkhardt BR, Loiler SA, Anderson JA, Kilberg MS, Crawford JM, Flotte TR, Goudy KS, Ellis TM, Atkinson M. Glucose-responsive expression of the human insulin promoter in HepG2 human hepatoma cells. Annals of the New York Academy of Sciences. 1005: 237-41. PMID 14679068 DOI: 10.1196/Annals.1288.035 |
0.3 |
|
| 2003 |
Litherland SA, She JX, Schatz D, Fuller K, Hutson AD, Peng RH, Li Y, Grebe KM, Whittaker DS, Bahjat K, Hopkins D, Fang Q, Spies PD, North K, Wasserfall C, ... Atkinson M, et al. Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset. Pediatric Diabetes. 4: 10-8. PMID 14655518 DOI: 10.1034/J.1399-5448.2003.00042.X |
0.481 |
|
| 2003 |
Schatz D, Gale EAM, Atkinson MA. Why Can't We Prevent Type I Diabetes?: Maybe it's time to try a different combination Diabetes Care. 26: 3326-3328. PMID 14633822 DOI: 10.2337/Diacare.26.12.3326 |
0.506 |
|
| 2003 |
Atkinson M, Gale EAM. Infant diets and type 1 diabetes: too early, too late, or just too complicated? Jama. 290: 1771-1772. PMID 14519713 DOI: 10.1001/Jama.290.13.1771 |
0.391 |
|
| 2003 |
Goudy KS, Burkhardt BR, Wasserfall C, Song S, Campbell-Thompson ML, Brusko T, Powers MA, Clare-Salzler MJ, Sobel ES, Ellis TM, Flotte TR, Atkinson MA. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. Journal of Immunology (Baltimore, Md. : 1950). 171: 2270-8. PMID 12928371 DOI: 10.4049/Jimmunol.171.5.2270 |
0.687 |
|
| 2003 |
Loiler SA, Conlon TJ, Song S, Tang Q, Warrington KH, Agarwal A, Kapturczak M, Li C, Ricordi C, Atkinson MA, Muzyczka N, Flotte TR. Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver. Gene Therapy. 10: 1551-8. PMID 12907946 DOI: 10.1038/Sj.Gt.3302046 |
0.356 |
|
| 2003 |
Qin HY, Mahon JL, Atkinson MA, Chaturvedi P, Lee-Chan E, Singh B. Type 1 diabetes alters anti-hsp90 autoantibody isotype Journal of Autoimmunity. 20: 237-245. PMID 12753809 DOI: 10.1016/S0896-8411(03)00035-0 |
0.48 |
|
| 2003 |
Chen S, Agarwal A, Glushakova OY, Jorgensen MS, Salgar SK, Poirier A, Flotte TR, Croker BP, Madsen KM, Atkinson MA, Hauswirth WW, Berns KI, Tisher CC. Gene delivery in renal tubular epithelial cells using recombinant adeno-associated viral vectors. Journal of the American Society of Nephrology : Jasn. 14: 947-58. PMID 12660329 DOI: 10.1097/01.Asn.0000057858.45649.F7 |
0.306 |
|
| 2003 |
Zhang YC, Pileggi A, Agarwal A, Molano RD, Powers M, Brusko T, Wasserfall C, Goudy K, Zahr E, Poggioli R, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Nick H, Flotte T, ... ... Atkinson MA, et al. Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes. 52: 708-16. PMID 12606512 DOI: 10.2337/Diabetes.52.3.708 |
0.641 |
|
| 2002 |
Atkinson MA, Wilson SB. Fatal attraction: chemokines and type 1 diabetes. The Journal of Clinical Investigation. 110: 1611-3. PMID 12464665 DOI: 10.1172/Jci17311 |
0.514 |
|
| 2002 |
Zhang YC, Molano RD, Pileggi A, Powers M, Cross J, Wasserfall C, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Flotte T, Ellis TM, Ricordi C, Atkinson MA, Inverardi L. Adeno-associated virus transduction of islets with interleukin-4 results in impaired metabolic function in syngeneic marginal islet mass transplantation. Transplantation. 74: 1184-6. PMID 12438968 DOI: 10.1097/00007890-200210270-00022 |
0.363 |
|
| 2002 |
Kapturczak M, Zolotukhin S, Cross J, Pileggi A, Molano RD, Jorgensen M, Byrne B, Flotte TR, Ellis T, Inverardi L, Ricordi C, Nick H, Atkinson M, Agarwal A. Transduction of human and mouse pancreatic islet cells using a bicistronic recombinant adeno-associated viral vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 5: 154-60. PMID 11829522 DOI: 10.1006/Mthe.2002.0522 |
0.368 |
|
| 2001 |
Kapturczak MH, Flotte T, Atkinson MA. Adeno-Associated Virus (AAV) as a vehicle for therapeutic gene delivery: Improvements in vector design and viral production enhance potential to prolong graft survival in pancreatic islet cell transplantation for the reversal of type 1 diabetes Current Molecular Medicine. 1: 245-258. PMID 11899074 DOI: 10.2174/1566524013363979 |
0.423 |
|
| 2001 |
Brod SA, Atkinson M, Lavis VR, Brosnan PG, Hardin DS, Orlander PR, Nguyen M, Riley WJ. Ingested IFN-α preserves residual β cell function in type 1 diabetes Journal of Interferon and Cytokine Research. 21: 1021-1030. PMID 11798459 DOI: 10.1089/107999001317205141 |
0.457 |
|
| 2001 |
Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TWH, Lee-Chan E, Singh B. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes. 50: 2451-2458. PMID 11679421 DOI: 10.2337/Diabetes.50.11.2451 |
0.441 |
|
| 2001 |
Atkinson MA, Eisenbarth GS. Type 1 diabetes: New perspectives on disease pathogenesis and treatment Lancet. 358: 221-229. PMID 11476858 DOI: 10.1016/S0140-6736(01)05415-0 |
0.474 |
|
| 2001 |
Peakman M, Tree TI, Endl J, Van Endert P, Atkinson MA, Roep BO. Characterization of Preparations of GAD65, Proinsulin, and the Islet Tyrosine Phosphatase IA-2 for Use in Detection of Autoreactive T-Cells in Type 1 Diabetes: Report of Phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell Assays in Type 1 Diabetes Diabetes. 50: 1749-1754. PMID 11473034 DOI: 10.2337/Diabetes.50.8.1749 |
0.498 |
|
| 2001 |
Tisch R, Wang B, Atkinson MA, Serreze DV, Friedline R. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice Journal of Immunology. 166: 6925-6936. PMID 11359854 DOI: 10.4049/Jimmunol.166.11.6925 |
0.453 |
|
| 2001 |
Flotte T, Agarwal A, Wang J, Song S, Fenjves ES, Inverardi L, Chesnut K, Afione S, Loiler S, Wasserfall C, Kapturczak M, Ellis T, Nick H, Atkinson M. Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors. Diabetes. 50: 515-20. PMID 11246870 DOI: 10.2337/Diabetes.50.3.515 |
0.376 |
|
| 2001 |
Haskins K, Atkinson M. Prediction of diabetes and response to therapy in individual animals: Are there lessons for man? Report on the JDF/Snow Mountain meeting, 5-7 October 2000, Winter Park, CO, USA Journal of Autoimmunity. 16: 15-19. PMID 11221992 DOI: 10.1006/Jaut.2000.0467 |
0.395 |
|
| 2001 |
Bingley PJ, Bonifacio E, Ziegler AG, Schatz DA, Atkinson MA, Eisenbarth GS. Proposed guidelines on screening for risk of type 1 diabetes Diabetes Care. 24: 398. PMID 11213898 DOI: 10.2337/Diacare.24.2.398 |
0.501 |
|
| 2000 |
Atkinson M, Honeyman M, Peakman M, Roep B. T-cell markers in type I diabetes: progress, prospects and realistic expectations. Diabetologia. 43: 819-820. PMID 10907132 DOI: 10.1007/S001250070001 |
0.501 |
|
| 2000 |
Serreze DV, Ottendorfer EW, Elliss TM, Gauntt CJ, Atkinson MA. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets Diabetes. 49: 708-711. PMID 10905477 DOI: 10.2337/Diabetes.49.5.708 |
0.482 |
|
| 2000 |
Atkinson MA. The $64,000 question in diabetes continues . . Lancet. 355: 4-6. PMID 10892753 DOI: 10.1016/S0140-6736(00)02421-1 |
0.468 |
|
| 2000 |
Atkinson M, Ellis T, Serreze D. Control of Autoimmune Diabetes Science. 287: 191-191. DOI: 10.1126/Science.287.5451.191A |
0.365 |
|
| 1999 |
Ottendorfer E, Ellis TM, Bahjat KS, Clare-Salzler M, Atkinson MA. No alteration in T lymphocyte expression of CD40 ligand (CD154) in individuals with or at increased risk for insulin-dependent diabetes mellitus Journal of Clinical Endocrinology and Metabolism. 84: 4068-4072. PMID 10566651 DOI: 10.1210/Jcem.84.11.6107 |
0.472 |
|
| 1999 |
Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, Sachs JA. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays. Journal of Autoimmunity. 13: 267-82. PMID 10479395 DOI: 10.1006/Jaut.1999.0312 |
0.508 |
|
| 1999 |
Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: As good as it gets? Nature Medicine. 5: 601-604. PMID 10371488 DOI: 10.1038/9442 |
0.463 |
|
| 1999 |
Ellis T, Jodoin E, Ottendorfer E, Salisbury P, She JX, Schatz D, Atkinson MA. Cellular immune responses against proinsulin: No evidence for enhanced reactivity in individuals with IDDM Diabetes. 48: 299-303. PMID 10334305 DOI: 10.2337/Diabetes.48.2.299 |
0.304 |
|
| 1999 |
Falta MT, Magin GK, Allegretta M, Steinman L, Atkinson MA, Brostoff SW, Albertini RJ. Selection of hprt mutant T cells as surrogates for dividing cells reveals a restricted T cell receptor BV repertoire in insulin-dependent diabetes mellitus Clinical Immunology. 90: 340-351. PMID 10075863 DOI: 10.1006/Clim.1998.4664 |
0.43 |
|
| 1999 |
Leslie RD, Atkinson MA, Notkins AL. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes. Diabetologia. 42: 3-14. PMID 10027571 DOI: 10.1007/S001250051105 |
0.46 |
|
| 1999 |
Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, Strominger JL, Hafler DA. Erratum: Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes Nature. 399: 84-84. DOI: 10.1038/20007 |
0.501 |
|
| 1998 |
Ellis TM, Ottendorfer E, Jodoin E, Salisbury PJ, She JX, Schatz DA, Atkinson MA. Cellular immune responses to β casein: Elevated in but not specific for individuals with Type I diabetes mellitus Diabetologia. 41: 731-735. PMID 9662058 DOI: 10.1007/S001250050976 |
0.47 |
|
| 1998 |
Ellis TM, Schatz DA, Ottendorfer EW, Lan MS, Wasserfall C, Salisbury PJ, She JX, Notkins AL, Maclaren NK, Atkinson MA. The relationship between humoral and cellular immunity to IA-2 in IDDM Diabetes. 47: 566-569. PMID 9568688 DOI: 10.2337/Diabetes.47.4.566 |
0.371 |
|
| 1998 |
Zechel MA, Elliott JF, Atkinson MA, Singh B. Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice Journal of Autoimmunity. 11: 83-95. PMID 9480726 DOI: 10.1006/Jaut.1997.0178 |
0.443 |
|
| 1998 |
Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, Strominger JL, Hafler DA. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature. 391: 177-81. PMID 9428763 DOI: 10.1038/34419 |
0.54 |
|
| 1997 |
Atkinson MA. Molecular mimicry and the pathogenesis of insulin-dependent diabetes mellitus: Still just an attractive hypothesis Annals of Medicine. 29: 393-399. PMID 9453286 DOI: 10.3109/07853899708999368 |
0.439 |
|
| 1997 |
Cetkovic-Cvrlje M, Gerling IC, Muir A, Atkinson MA, Elliott JF, Leiter EH. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate β-cell antigens Diabetes. 46: 1975-1982. PMID 9392483 DOI: 10.2337/Diab.46.12.1975 |
0.45 |
|
| 1997 |
Maclaren NK, Atkinson MA. Insulin-dependent diabetes mellitus: the hypothesis of molecular mimicry between islet cell antigens and microorganisms Molecular Medicine Today. 3: 76-83. PMID 9060005 DOI: 10.1016/S1357-4310(96)10056-3 |
0.484 |
|
| 1996 |
Tian J, Clare-Salzler M, Herschenfeld A, Middleton B, Newman D, Mueller R, Arita S, Evans C, Atkinson MA, Mullen Y, Sarvetnick N, Tobin AJ, Lehmann PV, Kaufman DL. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nature Medicine. 2: 1348-53. PMID 8946834 DOI: 10.1038/Nm1296-1348 |
0.452 |
|
| 1996 |
Bowman MA, Simell OG, Peck AB, Cornelius J, Luchetta R, Look Z, Maclaren NK, Atkinson MA. Pharmacokinetics of aminoguanidine administration and effects on the diabetes frequency in nonobese diabetic mice Journal of Pharmacology and Experimental Therapeutics. 279: 790-794. PMID 8930185 |
0.376 |
|
| 1996 |
Ellis TM, Atkinson MA. Early infant diets and insulin-dependent diabetes Lancet. 347: 1464-1465. PMID 8676633 DOI: 10.1016/S0140-6736(96)91690-6 |
0.38 |
|
| 1996 |
Aanstoot HJ, Kang SM, Kim J, Lindsay LA, Roll U, Knip M, Atkinson M, Mose-Larsen P, Fey S, Ludvigsson J, Landin L, Bruining J, Maclaren N, Akerblom HK, Baekkeskov S. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes. Journal of Clinical Investigation. 97: 2772-2783. PMID 8675688 DOI: 10.1172/Jci118732 |
0.478 |
|
| 1996 |
Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Kaufman DL. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes Journal of Experimental Medicine. 183: 1561-1567. PMID 8666914 DOI: 10.1084/Jem.183.4.1561 |
0.301 |
|
| 1996 |
Ellis TM, Atkinson MA. The clinical significance of an autoimmune response against glutamic acid decarboxylase Nature Medicine. 2: 148-153. PMID 8574952 DOI: 10.1038/Nm0296-148 |
0.418 |
|
| 1996 |
Bowman MA, Campbell L, Darrow BL, Ellis TM, Suresh A, Atkinson MA. Immunological and metabolic effects of prophylactic insulin therapy in the NOD-scid/scid adoptive transfer model of IDDM. Diabetes. 45: 205-8. PMID 8549866 DOI: 10.2337/Diab.45.2.205 |
0.31 |
|
| 1994 |
Dosch HM, Karjalainen J, VanderMeulen J, Atkinson MA, Kao KJ, Maclaren NK. Lack of immunity to bovine serum albumin in insulin-dependent diabetes mellitus [3] New England Journal of Medicine. 330: 1616-1617. PMID 8177260 DOI: 10.1056/NEJM199406023302216 |
0.349 |
|
| 1994 |
Atkinson MA, Maclaren NK. Mechanisms of disease: The pathogenesis of insulin-dependent diabetes mellitus New England Journal of Medicine. 331: 1428-1436. PMID 7969282 DOI: 10.1056/Nejm199411243312107 |
0.426 |
|
| 1994 |
Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. The Journal of Clinical Investigation. 94: 2125-9. PMID 7962558 DOI: 10.1172/Jci117567 |
0.412 |
|
| 1994 |
Schoot M, Schatz D, Atkinson M, Krischer J, Mehta H, Vold B, Maclaren N. GAD65 Autoantibodies Increase the Predictability but not the Sensitivity of Islet Cell and Insulin Autoantibodies for Developing Insulin Dependent Diabetes Mellitus Journal of Autoimmunity. 7: 865-872. PMID 7888042 DOI: 10.1006/Jaut.1994.1070 |
0.426 |
|
| 1994 |
Gerling IC, Atkinson MA, Leiter EH. The thymus as a site for evaluating the potency of candidate β cell autoantigens in NOD mice Journal of Autoimmunity. 7: 851-858. PMID 7888041 DOI: 10.1006/Jaut.1994.1068 |
0.497 |
|
| 1994 |
Harrison LC, Honeyman MC, Deaizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS, Atkinson M, Leslie DRG. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Journal of Endocrinological Investigation. 17: 581-584. PMID 7829833 DOI: 10.1007/Bf03347753 |
0.404 |
|
| 1994 |
Bowman MA, Leiter EH, Atkinson MA. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease Trends in Immunology. 15: 115-120. DOI: 10.1016/0167-5699(94)90154-6 |
0.418 |
|
| 1993 |
Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. The Journal of Clinical Investigation. 91: 350-6. PMID 8423231 DOI: 10.1172/Jci116192 |
0.445 |
|
| 1993 |
Atkinson MA, Maclaren NK. Islet cell autoantigens in insulin-dependent diabetes Journal of Clinical Investigation. 92: 1608-1616. PMID 8408615 DOI: 10.1172/Jci116745 |
0.422 |
|
| 1993 |
Atkinson MA, Bowman MA, Kao KJ, Campbell L, Dush PJ, Shah SC, Simell O, Maclaren NK. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes New England Journal of Medicine. 329: 1853-1858. PMID 8247037 DOI: 10.1056/Nejm199312163292505 |
0.385 |
|
| 1993 |
Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GS, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366: 69-72. PMID 7694152 DOI: 10.1038/366069A0 |
0.451 |
|
| 1992 |
Maclaren N, Atkinson M. Is Insulin-Dependent Diabetes Mellitus Environmentally Induced? The New England Journal of Medicine. 327: 348-349. PMID 1620174 DOI: 10.1056/Nejm199207303270509 |
0.456 |
|
| 1992 |
Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. The Journal of Clinical Investigation. 89: 283-92. PMID 1370298 DOI: 10.1172/Jci115573 |
0.449 |
|
| 1992 |
Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu DF, Erlander MG, Tobin AJ, Maclaren NK. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet. 339: 458-9. PMID 1346821 DOI: 10.1016/0140-6736(92)91061-C |
0.491 |
|
| 1991 |
Atkinson MA, Holmes LA, Scharp DW, Lacy PE, Maclaren NK. No evidence for serological autoimmunity to islet cell heat shock proteins in insulin dependent diabetes Journal of Clinical Investigation. 87: 721-724. PMID 1991854 DOI: 10.1172/Jci115051 |
0.394 |
|
| 1990 |
Atkinson MA, Maclaren NK. What causes diabetes? Scientific American. 263: 62-71. PMID 2197720 DOI: 10.1038/Scientificamerican0790-62 |
0.461 |
|
| 1990 |
Atkinson MA, Maclaren NK, Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy Diabetes. 39: 933-937. PMID 2197139 DOI: 10.2337/Diab.39.8.933 |
0.376 |
|
| 1990 |
Riley WJ, Atkinson MA, Schatz DA, Maclaren NK. Comparison of islet autoantibodies in 'pre-diabetes' and recommendations for screening Journal of Autoimmunity. 3: 47-51. PMID 2187460 DOI: 10.1016/S0896-8411(09)90009-9 |
0.422 |
|
| 1990 |
Atkinson MA, Maclaren NK, Holmes L, Scharp DW, Lacy PE, Riley WJ. The natural history and predictive value of M(r) 64,000 autoantibodies for insulin-dependent diabetes mellitus Journal of Autoimmunity. 3: 41-45. PMID 2187459 DOI: 10.1016/S0896-8411(09)90008-7 |
0.397 |
|
| 1990 |
Atkinson MA, Maclaren NK, Riley WJ, Sharp DW, Lacey PE. 64 000 Mr autoantibodies as predictors of insulin-dependent diabetes The Lancet. 335: 1357-1360. PMID 1971659 DOI: 10.1016/0140-6736(90)91241-2 |
0.454 |
|
| 1988 |
Atkinson MA, Winter WE, Skordis N, Beppu H, Riley WM, Maclaren NK. Dietary protein restriction reduces the frequency and delays the onset of insulin dependent diabetes in BB rats Autoimmunity. 2: 11-19. PMID 3155150 DOI: 10.3109/08916938809019939 |
0.362 |
|
| 1988 |
Riley WJ, Atkinson MA, MacLaren NK. Insulin autoantibodies in pre-diabetes Advances in Experimental Medicine and Biology. 246: 45-51. PMID 3074667 DOI: 10.1007/978-1-4684-5616-5_6 |
0.49 |
|
| 1988 |
Atkinson MA, Maclaren NK. Autoantibodies in nonobese diabetic mice immunoprecipitate 64,000-M(r) islet antigen Diabetes. 37: 1587-1590. PMID 3053305 DOI: 10.2337/Diab.37.11.1587 |
0.485 |
|
| 1988 |
Maclaren N, Riley W, Skordis N, Atkinson M, Spillar R, Silverstein J, Klein R, Vadheim C, Rotter J. Inherited susceptibility to insulin-dependent diabetes is associated with HLA-DR1, while DR5 is protective. Autoimmunity. 1: 197-205. PMID 2979618 DOI: 10.3109/08916938808997164 |
0.321 |
|
| 1986 |
Atkinson MA, Maclaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP. Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes. 35: 894-898. PMID 3525287 DOI: 10.2337/Diab.35.8.894 |
0.355 |
|
| Show low-probability matches. |